false12/31Q120220000021344http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201912Member00000213442022-01-012022-04-010000021344ko:CommonStock0.25ParValueMember2022-01-012022-04-010000021344ko:A0.500NotesDue2024Member2022-01-012022-04-010000021344ko:A1.875NotesDue2026Member2022-01-012022-04-010000021344ko:A0.750NotesDue2026Member2022-01-012022-04-010000021344ko:A1.125NotesDue2027Member2022-01-012022-04-010000021344ko:A125NotesDue2029KO29AMember2022-01-012022-04-010000021344ko:A125NotesDue2029KO29BMember2022-01-012022-04-010000021344ko:A400NotesDue2030Member2022-01-012022-04-010000021344ko:A1.250NotesDue2031Member2022-01-012022-04-010000021344ko:A375NotesDue2033Member2022-01-012022-04-010000021344ko:A500NotesDue2033Member2022-01-012022-04-010000021344ko:A1.625NotesDue2035Member2022-01-012022-04-010000021344ko:A1.100NotesDue2036Member2022-01-012022-04-010000021344ko:A950NotesDue2036Member2022-01-012022-04-010000021344ko:A800NotesDue2040Member2022-01-012022-04-010000021344ko:A1000NotesDue2041Member2022-01-012022-04-0100000213442022-04-26xbrli:sharesiso4217:USD00000213442021-01-012021-04-02iso4217:USDxbrli:shares00000213442022-04-0100000213442021-12-3100000213442020-12-3100000213442021-04-020000021344us-gaap:OtherNoncurrentAssetsMember2022-04-010000021344us-gaap:OtherNoncurrentAssetsMember2021-12-310000021344us-gaap:OtherNoncurrentAssetsMember2021-04-020000021344us-gaap:OtherNoncurrentAssetsMember2020-12-310000021344ko:ConcentrateOperationsMembercountry:US2022-01-012022-04-010000021344ko:ConcentrateOperationsMemberko:InternationalMember2022-01-012022-04-010000021344ko:ConcentrateOperationsMember2022-01-012022-04-010000021344ko:FinishedProductOperationsMembercountry:US2022-01-012022-04-010000021344ko:FinishedProductOperationsMemberko:InternationalMember2022-01-012022-04-010000021344ko:FinishedProductOperationsMember2022-01-012022-04-010000021344country:US2022-01-012022-04-010000021344ko:InternationalMember2022-01-012022-04-010000021344ko:ConcentrateOperationsMembercountry:US2021-01-012021-04-020000021344ko:ConcentrateOperationsMemberko:InternationalMember2021-01-012021-04-020000021344ko:ConcentrateOperationsMember2021-01-012021-04-020000021344ko:FinishedProductOperationsMembercountry:US2021-01-012021-04-020000021344ko:FinishedProductOperationsMemberko:InternationalMember2021-01-012021-04-020000021344ko:FinishedProductOperationsMember2021-01-012021-04-020000021344country:US2021-01-012021-04-020000021344ko:InternationalMember2021-01-012021-04-020000021344ko:MarketableSecuritiesMember2022-04-010000021344us-gaap:OtherInvestmentsMember2022-04-010000021344ko:MarketableSecuritiesMember2021-12-310000021344us-gaap:OtherInvestmentsMember2021-12-3100000213442021-01-012021-12-310000021344ko:MarketableSecuritiesMemberko:TradingSecuritiesMember2022-04-010000021344us-gaap:AvailableforsaleSecuritiesMemberko:MarketableSecuritiesMember2022-04-010000021344ko:MarketableSecuritiesMemberko:TradingSecuritiesMember2021-12-310000021344us-gaap:AvailableforsaleSecuritiesMemberko:MarketableSecuritiesMember2021-12-310000021344us-gaap:OtherNoncurrentAssetsMemberko:TradingSecuritiesMember2022-04-010000021344us-gaap:AvailableforsaleSecuritiesMemberus-gaap:OtherNoncurrentAssetsMember2022-04-010000021344us-gaap:OtherNoncurrentAssetsMemberko:TradingSecuritiesMember2021-12-310000021344us-gaap:AvailableforsaleSecuritiesMemberus-gaap:OtherNoncurrentAssetsMember2021-12-310000021344ko:TradingSecuritiesMember2022-04-010000021344us-gaap:AvailableforsaleSecuritiesMember2022-04-010000021344ko:TradingSecuritiesMember2021-12-310000021344us-gaap:AvailableforsaleSecuritiesMember2021-12-310000021344us-gaap:DebtSecuritiesMember2022-01-012022-04-010000021344us-gaap:DebtSecuritiesMember2021-01-012021-04-020000021344us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-04-010000021344us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2021-12-310000021344us-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2022-04-010000021344us-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2021-12-310000021344us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-04-010000021344us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2021-12-310000021344us-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateContractMember2022-04-010000021344us-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateContractMember2021-12-310000021344us-gaap:DesignatedAsHedgingInstrumentMember2022-04-010000021344us-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000021344us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:ForeignExchangeContractMember2022-04-010000021344us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:ForeignExchangeContractMember2021-12-310000021344us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2022-04-010000021344us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2021-12-310000021344us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:InterestRateContractMember2022-04-010000021344us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:InterestRateContractMember2021-12-310000021344us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-04-010000021344us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2021-12-310000021344us-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2022-04-010000021344us-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2021-12-310000021344us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-04-010000021344us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2021-12-310000021344us-gaap:OtherNoncurrentAssetsMemberus-gaap:CommodityContractMemberus-gaap:NondesignatedMember2022-04-010000021344us-gaap:OtherNoncurrentAssetsMemberus-gaap:CommodityContractMemberus-gaap:NondesignatedMember2021-12-310000021344us-gaap:OtherContractMemberus-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-04-010000021344us-gaap:OtherContractMemberus-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2021-12-310000021344us-gaap:NondesignatedMember2022-04-010000021344us-gaap:NondesignatedMember2021-12-310000021344us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2022-04-010000021344us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2021-12-310000021344us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentLiabilitiesMember2022-04-010000021344us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentLiabilitiesMember2021-12-310000021344us-gaap:CommodityContractMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:NondesignatedMember2022-04-010000021344us-gaap:CommodityContractMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:NondesignatedMember2021-12-310000021344us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentLiabilitiesMember2022-04-010000021344us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentLiabilitiesMember2021-12-310000021344us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-04-010000021344us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2021-12-310000021344us-gaap:CurrencySwapMemberus-gaap:CashFlowHedgingMember2022-04-010000021344us-gaap:CurrencySwapMemberus-gaap:CashFlowHedgingMember2021-12-310000021344us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2021-12-310000021344us-gaap:SalesMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-01-012022-04-010000021344us-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2022-01-012022-04-010000021344us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-01-012022-04-010000021344us-gaap:OtherIncomeMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-01-012022-04-010000021344us-gaap:CashFlowHedgingMember2022-01-012022-04-010000021344us-gaap:SalesMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2021-01-012021-04-020000021344us-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2021-01-012021-04-020000021344us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2021-01-012021-04-020000021344us-gaap:OtherIncomeMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2021-01-012021-04-020000021344us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateContractMember2021-01-012021-04-020000021344us-gaap:CashFlowHedgingMember2021-01-012021-04-020000021344us-gaap:InterestRateSwapMemberus-gaap:FairValueHedgingMember2022-04-010000021344us-gaap:InterestRateSwapMemberus-gaap:FairValueHedgingMember2021-12-310000021344us-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateContractMember2022-01-012022-04-010000021344us-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateContractMember2021-01-012021-04-020000021344us-gaap:DebtMemberus-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMember2022-01-012022-04-010000021344us-gaap:DebtMemberus-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMember2021-01-012021-04-020000021344us-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMember2022-01-012022-04-010000021344us-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMember2021-01-012021-04-020000021344us-gaap:FairValueHedgingMember2022-01-012022-04-010000021344us-gaap:FairValueHedgingMember2021-01-012021-04-020000021344us-gaap:ShortTermDebtMemberus-gaap:FairValueHedgingMember2022-04-010000021344us-gaap:ShortTermDebtMemberus-gaap:FairValueHedgingMember2021-12-310000021344us-gaap:FairValueHedgingMemberus-gaap:LongTermDebtMember2022-04-010000021344us-gaap:FairValueHedgingMemberus-gaap:LongTermDebtMember2021-12-310000021344us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2022-04-010000021344us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2021-12-310000021344us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2022-01-012022-04-010000021344us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2021-01-012021-04-020000021344us-gaap:NetInvestmentHedgingMemberko:ForeignCurrencyDenominatedDebtMember2022-04-010000021344us-gaap:NetInvestmentHedgingMemberko:ForeignCurrencyDenominatedDebtMember2021-12-310000021344us-gaap:NetInvestmentHedgingMemberko:ForeignCurrencyDenominatedDebtMember2022-01-012022-04-010000021344us-gaap:NetInvestmentHedgingMemberko:ForeignCurrencyDenominatedDebtMember2021-01-012021-04-020000021344us-gaap:NetInvestmentHedgingMember2022-04-010000021344us-gaap:NetInvestmentHedgingMember2021-12-310000021344us-gaap:NetInvestmentHedgingMember2022-01-012022-04-010000021344us-gaap:NetInvestmentHedgingMember2021-01-012021-04-020000021344us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2022-04-010000021344us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2021-12-310000021344us-gaap:NondesignatedMemberus-gaap:InterestRateContractMember2021-12-310000021344us-gaap:CommodityContractMemberus-gaap:NondesignatedMember2022-04-010000021344us-gaap:CommodityContractMemberus-gaap:NondesignatedMember2021-12-310000021344us-gaap:SalesMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2022-01-012022-04-010000021344us-gaap:SalesMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2021-01-012021-04-020000021344us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2022-01-012022-04-010000021344us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2021-01-012021-04-020000021344us-gaap:OtherIncomeMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2022-01-012022-04-010000021344us-gaap:OtherIncomeMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2021-01-012021-04-020000021344us-gaap:InterestExpenseMemberus-gaap:NondesignatedMemberus-gaap:InterestRateContractMember2022-01-012022-04-010000021344us-gaap:InterestExpenseMemberus-gaap:NondesignatedMemberus-gaap:InterestRateContractMember2021-01-012021-04-020000021344us-gaap:CommodityContractMemberus-gaap:CostOfSalesMemberus-gaap:NondesignatedMember2022-01-012022-04-010000021344us-gaap:CommodityContractMemberus-gaap:CostOfSalesMemberus-gaap:NondesignatedMember2021-01-012021-04-020000021344us-gaap:GeneralAndAdministrativeExpenseMemberus-gaap:OtherContractMemberus-gaap:NondesignatedMember2022-01-012022-04-010000021344us-gaap:GeneralAndAdministrativeExpenseMemberus-gaap:OtherContractMemberus-gaap:NondesignatedMember2021-01-012021-04-020000021344us-gaap:OtherIncomeMemberus-gaap:OtherContractMemberus-gaap:NondesignatedMember2022-01-012022-04-010000021344us-gaap:OtherIncomeMemberus-gaap:OtherContractMemberus-gaap:NondesignatedMember2021-01-012021-04-020000021344us-gaap:NondesignatedMember2022-01-012022-04-010000021344us-gaap:NondesignatedMember2021-01-012021-04-020000021344ko:FixedInterestRateDebtWithAMaturityDateIn2022Member2022-01-012022-04-010000021344ko:FixedInterestRateDebtWithAMaturityDateIn2022Member2022-04-01xbrli:pure0000021344us-gaap:GuaranteeOfIndebtednessOfOthersMember2022-04-010000021344ko:TaxYears20072009Member2015-12-310000021344ko:TaxYears20072009Member2018-01-012018-03-300000021344ko:RiskManagementProgramsMember2022-04-010000021344ko:RiskManagementProgramsMember2021-12-310000021344us-gaap:ParentMember2022-04-010000021344us-gaap:ParentMember2021-12-310000021344ko:DivestituresdeconsolidationsandotherMemberus-gaap:OtherNonoperatingIncomeExpenseMember2022-01-012022-04-010000021344us-gaap:SalesMemberus-gaap:ForeignExchangeContractMember2022-01-012022-04-010000021344us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2022-01-012022-04-010000021344us-gaap:InterestExpenseMemberus-gaap:CrossCurrencyInterestRateContractMember2022-01-012022-04-010000021344us-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2022-01-012022-04-010000021344us-gaap:AvailableforsaleSecuritiesMemberus-gaap:OtherNonoperatingIncomeExpenseMember2022-01-012022-04-010000021344us-gaap:OtherNonoperatingIncomeExpenseMember2022-01-012022-04-010000021344us-gaap:CommonStockMember2021-12-310000021344us-gaap:RetainedEarningsMember2021-12-310000021344us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000021344us-gaap:AdditionalPaidInCapitalMember2021-12-310000021344us-gaap:TreasuryStockMember2021-12-310000021344us-gaap:NoncontrollingInterestMember2021-12-310000021344us-gaap:RetainedEarningsMember2022-01-012022-04-010000021344us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-04-010000021344us-gaap:NoncontrollingInterestMember2022-01-012022-04-010000021344us-gaap:TreasuryStockMember2022-01-012022-04-010000021344us-gaap:CommonStockMember2022-01-012022-04-010000021344us-gaap:AdditionalPaidInCapitalMember2022-01-012022-04-010000021344us-gaap:CommonStockMember2022-04-010000021344us-gaap:RetainedEarningsMember2022-04-010000021344us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-010000021344us-gaap:AdditionalPaidInCapitalMember2022-04-010000021344us-gaap:TreasuryStockMember2022-04-010000021344us-gaap:NoncontrollingInterestMember2022-04-010000021344us-gaap:CommonStockMember2020-12-310000021344us-gaap:RetainedEarningsMember2020-12-310000021344us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000021344us-gaap:AdditionalPaidInCapitalMember2020-12-310000021344us-gaap:TreasuryStockMember2020-12-310000021344us-gaap:NoncontrollingInterestMember2020-12-3100000213442020-01-012020-12-310000021344srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2020-12-310000021344srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2020-12-310000021344us-gaap:RetainedEarningsMember2021-01-012021-04-020000021344us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-04-020000021344us-gaap:NoncontrollingInterestMember2021-01-012021-04-020000021344us-gaap:CommonStockMember2021-01-012021-04-020000021344us-gaap:AdditionalPaidInCapitalMember2021-01-012021-04-020000021344us-gaap:TreasuryStockMember2021-01-012021-04-020000021344us-gaap:CommonStockMember2021-04-020000021344us-gaap:RetainedEarningsMember2021-04-020000021344us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-020000021344us-gaap:AdditionalPaidInCapitalMember2021-04-020000021344us-gaap:TreasuryStockMember2021-04-020000021344us-gaap:NoncontrollingInterestMember2021-04-020000021344ko:FairlifeMemberus-gaap:CorporateMember2022-01-012022-04-010000021344ko:ProductivityAndReinvestmentMember2022-01-012022-04-010000021344ko:NorthAmericaSegmentMemberus-gaap:OtherOperatingIncomeExpenseMember2022-01-012022-04-010000021344ko:BodyArmorMember2022-01-012022-04-010000021344ko:StrategicRealignmentMemberus-gaap:OtherOperatingIncomeExpenseMember2022-01-012022-04-010000021344ko:StrategicRealignmentMemberus-gaap:OtherOperatingIncomeExpenseMember2021-01-012021-04-020000021344ko:ProductivityAndReinvestmentMember2021-01-012021-04-020000021344ko:FairlifeMemberus-gaap:CorporateMember2021-01-012021-04-020000021344us-gaap:CorporateMember2021-01-012021-04-020000021344us-gaap:CorporateMember2022-01-012022-04-010000021344ko:StrategicRealignmentMemberus-gaap:OtherIncomeMember2021-01-012021-04-020000021344ko:ProductivityAndReinvestmentMember2022-04-010000021344us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-04-010000021344us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-04-020000021344us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-04-010000021344us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-04-020000021344us-gaap:FairValueInputsLevel1Member2022-04-010000021344us-gaap:FairValueInputsLevel2Member2022-04-010000021344us-gaap:FairValueInputsLevel3Member2022-04-010000021344us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-04-010000021344ko:FairValueMeasurementNettingAdjustmentMember2022-04-010000021344us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-04-010000021344us-gaap:OtherNoncurrentLiabilitiesMember2022-04-010000021344us-gaap:FairValueInputsLevel1Member2021-12-310000021344us-gaap:FairValueInputsLevel2Member2021-12-310000021344us-gaap:FairValueInputsLevel3Member2021-12-310000021344us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2021-12-310000021344ko:FairValueMeasurementNettingAdjustmentMember2021-12-310000021344us-gaap:OtherNoncurrentLiabilitiesMember2021-12-310000021344ko:EuropeMiddleEastAfricaMember2022-01-012022-04-010000021344ko:LatinAmericaSegmentMember2022-01-012022-04-010000021344ko:NorthAmericaSegmentMember2022-01-012022-04-010000021344ko:PacificMember2022-01-012022-04-010000021344ko:GlobalVenturesMember2022-01-012022-04-010000021344ko:BottlingInvestmentsMember2022-01-012022-04-010000021344ko:EliminationsMember2022-01-012022-04-010000021344ko:EuropeMiddleEastAfricaMember2022-04-010000021344ko:LatinAmericaSegmentMember2022-04-010000021344ko:NorthAmericaSegmentMember2022-04-010000021344ko:PacificMember2022-04-010000021344ko:GlobalVenturesMember2022-04-010000021344ko:BottlingInvestmentsMember2022-04-010000021344us-gaap:CorporateMember2022-04-010000021344ko:EliminationsMember2022-04-010000021344ko:EuropeMiddleEastAfricaMember2021-01-012021-04-020000021344ko:LatinAmericaSegmentMember2021-01-012021-04-020000021344ko:NorthAmericaSegmentMember2021-01-012021-04-020000021344ko:PacificMember2021-01-012021-04-020000021344ko:GlobalVenturesMember2021-01-012021-04-020000021344ko:BottlingInvestmentsMember2021-01-012021-04-020000021344ko:EliminationsMember2021-01-012021-04-020000021344ko:EuropeMiddleEastAfricaMember2021-04-020000021344ko:LatinAmericaSegmentMember2021-04-020000021344ko:NorthAmericaSegmentMember2021-04-020000021344ko:PacificMember2021-04-020000021344ko:GlobalVenturesMember2021-04-020000021344ko:BottlingInvestmentsMember2021-04-020000021344us-gaap:CorporateMember2021-04-020000021344ko:EliminationsMember2021-04-020000021344ko:EuropeMiddleEastAfricaMember2021-12-310000021344ko:LatinAmericaSegmentMember2021-12-310000021344ko:NorthAmericaSegmentMember2021-12-310000021344ko:PacificMember2021-12-310000021344ko:GlobalVenturesMember2021-12-310000021344ko:BottlingInvestmentsMember2021-12-310000021344us-gaap:CorporateMember2021-12-310000021344ko:EliminationsMember2021-12-310000021344ko:BodyArmorMemberko:NorthAmericaSegmentMember2022-01-012022-04-010000021344ko:BodyArmorMemberus-gaap:CorporateMember2022-01-012022-04-010000021344us-gaap:OperatingIncomeLossMemberko:NorthAmericaSegmentMember2022-01-012022-04-010000021344ko:ProductivityAndReinvestmentMemberus-gaap:CorporateMember2022-01-012022-04-010000021344ko:StrategicRealignmentMemberko:EuropeMiddleEastAfricaMember2021-01-012021-04-020000021344ko:LatinAmericaSegmentMemberko:StrategicRealignmentMember2021-01-012021-04-020000021344ko:StrategicRealignmentMemberko:NorthAmericaSegmentMember2021-01-012021-04-020000021344ko:StrategicRealignmentMemberko:PacificMember2021-01-012021-04-020000021344ko:StrategicRealignmentMemberus-gaap:CorporateMemberus-gaap:OperatingIncomeLossMember2021-01-012021-04-020000021344ko:StrategicRealignmentMemberus-gaap:CorporateMember2021-01-012021-04-020000021344us-gaap:OperatingIncomeLossMemberko:NorthAmericaSegmentMember2021-01-012021-04-020000021344ko:ProductivityAndReinvestmentMemberus-gaap:CorporateMember2021-01-012021-04-02

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended April 1, 2022
OR
 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                                    to                                     
Commission File Number 001-02217
ko-20220401_g1.jpg
COCA COLA CO
(Exact name of Registrant as specified in its charter)
Delaware   58-0628465
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
One Coca-Cola Plaza
Atlanta Georgia 30313
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (404) 676-2121
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.25 Par Value KO New York Stock Exchange
0.500% Notes Due 2024 KO24 New York Stock Exchange
1.875% Notes Due 2026 KO26 New York Stock Exchange
0.750% Notes Due 2026 KO26C New York Stock Exchange
1.125% Notes Due 2027 KO27 New York Stock Exchange
0.125% Notes Due 2029 KO29A New York Stock Exchange
0.125% Notes Due 2029 KO29B New York Stock Exchange
0.400% Notes Due 2030 KO30B New York Stock Exchange
1.250% Notes Due 2031 KO31 New York Stock Exchange
0.375% Notes Due 2033 KO33 New York Stock Exchange
0.500% Notes Due 2033 KO33A New York Stock Exchange
1.625% Notes Due 2035 KO35 New York Stock Exchange
1.100% Notes Due 2036 KO36 New York Stock Exchange
0.950% Notes Due 2036 KO36A New York Stock Exchange
0.800% Notes Due 2040 KO40B New York Stock Exchange
1.000% Notes Due 2041 KO41 New York Stock Exchange
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes     No 



Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes     No 
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer Accelerated filer 
Non-accelerated filer Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark if the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes     No 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.
Class of Common Stock    Shares Outstanding as of April 26, 2022
$0.25 Par Value   4,335,028,727




THE COCA-COLA COMPANY AND SUBSIDIARIES
Table of Contents
    Page
1
 
2
2
3
4
5
6
 



FORWARD-LOOKING STATEMENTS
This report contains information that may constitute “forward-looking statements.” Generally, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,” “will” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future — including statements relating to volume growth, share of sales and earnings per share growth, and statements expressing general views about future operating results — are forward-looking statements. Management believes that these forward-looking statements are reasonable as and when made. However, caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. Our Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause our Company’s actual results to differ materially from historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, the possibility that the assumptions used to calculate our estimated aggregate incremental tax and interest liability related to the potential unfavorable outcome of the ongoing tax dispute with the U.S. Internal Revenue Service could significantly change; those described in Part II, “Item 1A. Risk Factors” and elsewhere in this report and in our Annual Report on Form 10-K for the year ended December 31, 2021; and those described from time to time in our future reports filed with the Securities and Exchange Commission.
1


Part I. Financial Information
Item 1. Financial Statements
THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(In millions except per share data)
Three Months Ended
April 1,
2022
April 2,
2021
Net Operating Revenues $ 10,491  $ 9,020 
Cost of goods sold 4,091  3,505 
Gross Profit 6,400  5,515 
Selling, general and administrative expenses 2,967  2,669 
Other operating charges 28  124 
Operating Income 3,405  2,722 
Interest income 78  66 
Interest expense 182  442 
Equity income (loss) — net 262  279 
Other income (loss) — net (105) 138 
Income Before Income Taxes 3,458  2,763 
Income taxes 665  508 
Consolidated Net Income 2,793  2,255 
Less: Net income (loss) attributable to noncontrolling interests 12  10 
Net Income Attributable to Shareowners of The Coca-Cola Company $ 2,781  $ 2,245 
Basic Net Income Per Share1
$ 0.64  $ 0.52 
Diluted Net Income Per Share1
$ 0.64  $ 0.52 
Average Shares Outstanding — Basic 4,332  4,307 
Effect of dilutive securities 25  23 
Average Shares Outstanding — Diluted 4,357  4,330 
1 Calculated based on net income attributable to shareowners of The Coca-Cola Company.
Refer to Notes to Consolidated Financial Statements.


2


THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In millions)
Three Months Ended
April 1,
2022
April 2,
2021
Consolidated Net Income $ 2,793  $ 2,255 
Other Comprehensive Income:
Net foreign currency translation adjustments 1,009 
Net gains (losses) on derivatives 64  104 
 Net change in unrealized gains (losses) on available-for-sale debt securities (35) (60)
Net change in pension and other postretirement benefit liabilities 85  420 
Total Comprehensive Income 3,916  2,723 
Less: Comprehensive income (loss) attributable to noncontrolling interests
145  10 
Total Comprehensive Income Attributable to Shareowners of The Coca-Cola Company $ 3,771  $ 2,713 
Refer to Notes to Consolidated Financial Statements.



3


THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions except par value)
April 1,
2022
December 31,
2021
ASSETS
Current Assets  
Cash and cash equivalents $ 7,681  $ 9,684 
Short-term investments 736  1,242 
Total Cash, Cash Equivalents and Short-Term Investments 8,417  10,926 
Marketable securities 1,939  1,699 
Trade accounts receivable, less allowances of $512 and $516, respectively
4,641  3,512 
Inventories 3,741  3,414 
Prepaid expenses and other current assets 3,418  2,994 
Total Current Assets 22,156  22,545 
Equity method investments 18,198  17,598 
Other investments 788  818 
Other noncurrent assets 6,392  6,731 
Deferred income tax assets 2,006  2,129 
Property, plant and equipment, less accumulated depreciation of $9,104 and $8,942, respectively
9,784  9,920 
Trademarks with indefinite lives 14,388  14,465 
Goodwill 19,598  19,363 
Other intangible assets 754  785 
Total Assets $ 94,064  $ 94,354 
LIABILITIES AND EQUITY
Current Liabilities    
Accounts payable and accrued expenses $ 13,272  $ 14,619 
Loans and notes payable 3,610  3,307 
Current maturities of long-term debt 1,039  1,338 
Accrued income taxes 866  686 
Total Current Liabilities 18,787  19,950 
Long-term debt 37,052  38,116 
Other noncurrent liabilities 8,252  8,607 
Deferred income tax liabilities 3,132  2,821 
The Coca-Cola Company Shareowners’ Equity    
Common stock, $0.25 par value; authorized — 11,200 shares; issued — 7,040 shares
1,760  1,760 
Capital surplus 18,388  18,116 
Reinvested earnings 69,969  69,094 
Accumulated other comprehensive income (loss) (13,340) (14,330)
Treasury stock, at cost — 2,709 and 2,715 shares, respectively
(51,932) (51,641)
Equity Attributable to Shareowners of The Coca-Cola Company 24,845  22,999 
Equity attributable to noncontrolling interests 1,996  1,861 
Total Equity 26,841  24,860 
Total Liabilities and Equity $ 94,064  $ 94,354 
Refer to Notes to Consolidated Financial Statements.
4


THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
  Three Months Ended
  April 1,
2022
April 2,
2021
Operating Activities    
Consolidated net income $ 2,793  $ 2,255 
Depreciation and amortization 324  366 
Stock-based compensation expense 87  58 
Deferred income taxes 41  377 
Equity (income) loss — net of dividends (247) (250)
Foreign currency adjustments 100  (20)
Significant (gains) losses — net 25 
Other operating charges 38  69 
Other items (70) 157 
Net change in operating assets and liabilities (2,468) (1,377)
Net Cash Provided by Operating Activities 623  1,636 
Investing Activities    
Purchases of investments (835) (1,466)
Proceeds from disposals of investments 1,323  1,375 
Acquisitions of businesses, equity method investments and nonmarketable securities (5) (4)
Proceeds from disposals of businesses, equity method investments and nonmarketable securities 218 
Purchases of property, plant and equipment (217) (216)
Proceeds from disposals of property, plant and equipment 16  11 
Other investing activities (354) 17 
Net Cash Provided by (Used in) Investing Activities 146  (281)
Financing Activities  
Issuances of debt 1,052  5,588 
Payments of debt (1,045) (3,044)
Issuances of stock 449  183 
Purchases of stock for treasury (546) (104)
Dividends (1,906) (1,810)
Other financing activities (979) (449)
Net Cash Provided by (Used in) Financing Activities (2,975) 364 
Effect of Exchange Rate Changes on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
173  (18)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents during the period (2,033) 1,701 
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period 10,025  7,110 
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at End of Period 7,992  8,811 
Less: Restricted cash and restricted cash equivalents at end of period 311  327 
Cash and Cash Equivalents at End of Period $ 7,681  $ 8,484 
Refer to Notes to Consolidated Financial Statements.

5



THE COCA-COLA COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. They do not include all information and notes required by U.S. GAAP for complete financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the Notes to Consolidated Financial Statements included in the Annual Report on Form 10-K of The Coca-Cola Company for the year ended December 31, 2021.
When used in these notes, the terms “The Coca-Cola Company,” “Company,” “we,” “us” and “our” mean The Coca-Cola Company and all entities included in our consolidated financial statements. In the opinion of management, all adjustments (including normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended April 1, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. Sales of our ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters typically accounting for the highest sales volumes. The volume of sales in the beverage business may be affected by weather conditions.
Each of our quarterly reporting periods, other than the fourth quarter, ends on the Friday closest to the last day of the corresponding quarterly calendar period. The first quarter of 2022 and the first quarter of 2021 ended on April 1, 2022 and April 2, 2021, respectively. Our fourth quarter and our fiscal year end on December 31 regardless of the day of the week on which December 31 falls.
Advertising Costs
The Company’s accounting policy related to advertising costs for annual reporting purposes is to expense production costs of print, radio, television and other advertisements as of the first date the advertisements take place. All other marketing expenditures are expensed in the annual period in which the expenditure is incurred.
For quarterly reporting purposes, we allocate our estimated full year marketing expenditures that benefit multiple quarters to each of those quarters. We use the proportion of each quarter’s actual unit case volume to the estimated full year unit case volume as the basis for the allocation. This methodology results in our marketing expenditures being recognized at a standard rate per unit case. At the end of each quarter, we review our estimated full year unit case volume and our estimated full year marketing expenditures that benefit multiple quarters in order to evaluate if a change in estimate is necessary. The impact of any change in the full year estimate is recognized in the quarter in which the change in estimate occurs. Our full year marketing expenditures are not impacted by this interim accounting policy.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
We classify time deposits and other investments that are highly liquid and have maturities of three months or less at the date of purchase as cash equivalents or restricted cash equivalents, as applicable. Restricted cash and restricted cash equivalents generally consist of amounts held by our captive insurance companies, which are included in the line item other noncurrent assets on our consolidated balance sheet. We manage our exposure to counterparty credit risk through specific minimum credit standards, diversification of counterparties and procedures to monitor our concentrations of credit risk.
The following tables provide a summary of cash, cash equivalents, restricted cash and restricted cash equivalents that constitute the total amounts shown in our consolidated statements of cash flows (in millions):
April 1,
2022
December 31,
2021
Cash and cash equivalents $ 7,681  $ 9,684 
Restricted cash and restricted cash equivalents included in other noncurrent assets1,2
311  341 
Cash, cash equivalents, restricted cash and restricted cash equivalents $ 7,992  $ 10,025 
1Amounts represent restricted cash and restricted cash equivalents in our solvency capital portfolio set aside primarily to cover pension obligations in certain of our European and Canadian pension plans. Refer to Note 4.
2Restricted cash and restricted cash equivalents include amounts related to assets held for sale. Refer to Note 2.
6


April 2,
2021
December 31,
2020
Cash and cash equivalents $ 8,484  $ 6,795 
Restricted cash and restricted cash equivalents included in other noncurrent assets1
327  315 
Cash, cash equivalents, restricted cash and restricted cash equivalents $ 8,811  $ 7,110 
1Amounts represent restricted cash and restricted cash equivalents in our solvency capital portfolio set aside primarily to cover pension obligations in certain of our European and Canadian pension plans. Refer to Note 4.
NOTE 2: ACQUISITIONS AND DIVESTITURES
Acquisitions
Our Company’s acquisitions of businesses, equity method investments and nonmarketable securities totaled $5 million and $4 million during the three months ended April 1, 2022 and April 2, 2021, respectively.
Divestitures
Proceeds from disposals of businesses, equity method investments and nonmarketable securities during the three months ended April 1, 2022 and April 2, 2021 totaled $218 million and $2 million, respectively. In 2022, we sold our ownership interest in one of our equity method investments for cash proceeds of $123 million. We recognized a net gain of $13 million as a result of the sale, which was recorded in the line item other income (loss) — net in our consolidated statement of income.
Assets and Liabilities Held for Sale
The Company had certain bottling operations in Asia Pacific that met the criteria to be classified as held for sale. As a result, we were required to record their assets and liabilities at the lower of carrying value or fair value less any costs to sell. As the fair value less any costs to sell exceeded the carrying value, the related assets and liabilities were recorded at their carrying value. These assets and liabilities were included in the Bottling Investments operating segment. The Company expects these bottling operations to be refranchised during the second half of 2022.
The following table presents information related to the major classes of assets and liabilities that were classified as held for sale and were included in the line items prepaid expenses and other current assets and accounts payable and accrued expenses, respectively, in our consolidated balance sheets (in millions):
April 1,
2022
December 31, 2021
Cash, cash equivalents and short-term investments $ 220  $ 228 
Trade accounts receivable, less allowances 15  21 
Inventories 50  55 
Prepaid expenses and other current assets 42  36 
Other noncurrent assets 36 
Deferred income tax assets 6 
Property, plant and equipment — net 287  282 
Goodwill 36  37 
  Assets held for sale $ 692  $ 674 
Accounts payable and accrued expenses $ 137  $ 139 
Accrued income taxes 5 
Other noncurrent liabilities 9 
Deferred income tax liabilities 5 
  Liabilities held for sale $ 156  $ 157 
7


NOTE 3: NET OPERATING REVENUES
The following table presents net operating revenues disaggregated between the United States and International and further by line of business (in millions):
United States International Total
Three Months Ended April 1, 2022
Concentrate operations $ 1,641  $ 4,083  $ 5,724 
Finished product operations 1,882  2,885  4,767 
Total $ 3,523  $ 6,968  $ 10,491 
Three Months Ended April 2, 2021
Concentrate operations $ 1,410  $ 3,572  $ 4,982 
Finished product operations 1,483  2,555  4,038 
Total $ 2,893  $ 6,127  $ 9,020 
Refer to Note 16 for disclosures of net operating revenues by operating segment and Corporate.
NOTE 4: INVESTMENTS
Equity Securities
The carrying values of our equity securities were included in the following line items in our consolidated balance sheets (in millions):
Fair Value with Changes Recognized in Income Measurement Alternative — No Readily Determinable Fair Value
April 1, 2022
Marketable securities $ 357  $  
Other investments 745  43 
Other noncurrent assets 1,493   
Total equity securities $ 2,595  $ 43 
December 31, 2021
Marketable securities $ 376  $ — 
Other investments 771  47 
Other noncurrent assets 1,576  — 
Total equity securities $ 2,723  $ 47 
The calculation of net unrealized gains and losses recognized during the period related to equity securities still held at the end of the period is as follows (in millions):
Three Months Ended
April 1,
2022
April 2,
2021
Net gains (losses) recognized during the period related to equity securities $ (100) $ 155 
Less: Net gains (losses) recognized during the period related to equity securities sold
during the period
(132) 14 
Net unrealized gains (losses) recognized during the period related to equity securities
still held at the end of the period
$ 32  $ 141 
8


Debt Securities
Our debt securities consisted of the following (in millions):
Gross Unrealized Estimated
Fair Value
Cost Gains Losses
April 1, 2022
Trading securities
$ 41  $   $ (1) $ 40 
Available-for-sale securities
1,933  25  (165) 1,793 
Total debt securities
$ 1,974  $ 25  $ (166) $ 1,833 
December 31, 2021
Trading securities
$ 39  $ $ —  $ 40 
Available-for-sale securities
1,648  33  (132) 1,549 
Total debt securities
$ 1,687  $ 34  $ (132) $ 1,589 
The carrying values of our debt securities were included in the following line items in our consolidated balance sheets (in millions):
April 1, 2022 December 31, 2021
Trading Securities Available-for-Sale Securities Trading Securities Available-for-Sale Securities
Marketable securities
$ 40  $ 1,542  $ 40  $ 1,283 
Other noncurrent assets
  251  —  266 
Total debt securities $ 40  $ 1,793  $ 40  $ 1,549 
The contractual maturities of these available-for-sale debt securities as of April 1, 2022 were as follows (in millions):
Cost Estimated
Fair Value
Within 1 year $ 70  $ 68 
After 1 year through 5 years 1,649  1,504 
After 5 years through 10 years 43  57 
After 10 years 171  164 
Total $ 1,933  $ 1,793 
The Company expects that actual maturities may differ from the contractual maturities above because borrowers have the right to call or prepay certain obligations.
The sale and/or maturity of available-for-sale debt securities resulted in the following realized activity (in millions):
Three Months Ended
April 1,
2022
April 2,
2021
Gross gains $ 1  $
Gross losses (5) (4)
Proceeds 231  158 
Captive Insurance Companies
In accordance with local insurance regulations, our consolidated captive insurance companies are required to meet and maintain minimum solvency capital requirements. The Company elected to invest a majority of its solvency capital in a portfolio of marketable equity and debt securities. These securities are included in the disclosures above. The Company uses one of our consolidated captive insurance companies to reinsure group annuity insurance contracts that cover the obligations of certain of our European and Canadian pension plans. This captive’s solvency capital funds included total equity and debt securities of $1,580 million and $1,670 million as of April 1, 2022 and December 31, 2021, respectively, which are classified in the line item other noncurrent assets in our consolidated balance sheets because the assets are not available to satisfy our current obligations.
9


NOTE 5: INVENTORIES
Inventories consisted of the following (in millions):
April 1,
2022
December 31,
2021
Raw materials and packaging $ 2,274  $ 2,133 
Finished goods 1,165  982 
Other 302  299 
Total inventories $ 3,741  $ 3,414 
NOTE 6: HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
The following table presents the fair values of the Company’s derivative instruments that were designated and qualified as part of a hedging relationship (in millions):
 
Fair Value1,2
Derivatives Designated as Hedging Instruments
Balance Sheet Location1
April 1,
2022
December 31,
2021
Assets:      
Foreign currency contracts Prepaid expenses and other current assets $ 189  $ 151 
Foreign currency contracts Other noncurrent assets 66  27 
Interest rate contracts Prepaid expenses and other current assets  
Interest rate contracts Other noncurrent assets   282 
Total assets   $ 255  $ 461 
Liabilities:      
Foreign currency contracts Accounts payable and accrued expenses $ 40  $ 15 
Foreign currency contracts Other noncurrent liabilities 38  17 
Interest rate contracts Other noncurrent liabilities 442  14 
Total liabilities   $ 520  $ 46 
1All of the Company’s derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 15 for the net presentation of the Company’s derivative instruments.
2Refer to Note 15 for additional information related to the estimated fair value.
10


The following table presents the fair values of the Company’s derivative instruments that were not designated as hedging instruments (in millions):
 
Fair Value1,2
Derivatives Not Designated as Hedging Instruments
Balance Sheet Location1
April 1,
2022
December 31, 2021
Assets:      
Foreign currency contracts Prepaid expenses and other current assets $ 90  $ 53 
Foreign currency contracts Other noncurrent assets 11  — 
Commodity contracts Prepaid expenses and other current assets 270  131 
Commodity contracts Other noncurrent assets 18 
Other derivative instruments Prepaid expenses and other current assets 20 
Total assets   $ 409  $ 196 
Liabilities:      
Foreign currency contracts Accounts payable and accrued expenses $ 68  $ 34 
Foreign currency contracts Other noncurrent liabilities 1 
Commodity contracts Accounts payable and accrued expenses  
Commodity contracts Other noncurrent liabilities 3 
Total liabilities   $ 72  $ 50 
1All of the Company’s derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 15 for the net presentation of the Company’s derivative instruments.
2Refer to Note 15 for additional information related to the estimated fair value.
Credit Risk Associated with Derivatives
We have established strict counterparty credit guidelines and enter into transactions only with financial institutions of investment grade or better. We monitor counterparty exposures regularly and review any downgrade in credit rating immediately. If a downgrade in the credit rating of a counterparty were to occur, we have provisions requiring collateral for substantially all of our transactions. To mitigate presettlement risk, minimum credit standards become more stringent as the duration of the derivative financial instrument increases. In addition, the Company’s master netting agreements reduce credit risk by permitting the Company to net settle for transactions with the same counterparty. To minimize the concentration of credit risk, we enter into derivative transactions with a portfolio of financial institutions. Based on these factors, we consider the risk of counterparty default to be minimal.
Cash Flow Hedging Strategy
The Company uses cash flow hedges to minimize the variability in cash flows of assets or liabilities or forecasted transactions caused by fluctuations in foreign currency exchange rates, commodity prices or interest rates. The changes in the fair values of derivatives designated as cash flow hedges are recorded in accumulated other comprehensive income (loss) (“AOCI”) and are reclassified into the line item in our consolidated statement of income in which the hedged items are recorded in the same period the hedged items affect earnings. The changes in the fair values of hedges that are determined to be ineffective are immediately reclassified from AOCI into earnings. The maximum length of time for which the Company hedges its exposure to the variability in future cash flows is typically three years.
The Company maintains a foreign currency cash flow hedging program to reduce the risk that our U.S. dollar net cash inflows from sales outside the United States and U.S. dollar net cash outflows from procurement activities will be adversely affected by fluctuations in foreign currency exchange rates. We enter into forward contracts and purchase foreign currency options and collars (principally euro, British pound sterling and Japanese yen) to hedge certain portions of forecasted cash flows denominated in foreign currencies. When the U.S. dollar strengthens against the foreign currencies, the decline in the present value of future foreign currency cash flows is partially offset by gains in the fair value of the derivative instruments. Conversely, when the U.S. dollar weakens, the increase in the present value of future foreign currency cash flows is partially offset by losses in the fair value of the derivative instruments. The total notional values of derivatives that were designated and qualified for the Company’s foreign currency cash flow hedging program were $7,569 million and $7,399 million as of April 1, 2022 and December 31, 2021, respectively.
The Company uses cross-currency swaps to hedge the changes in cash flows of certain of its foreign currency denominated debt and other monetary assets or liabilities due to changes in foreign currency exchange rates. For this hedging program, the Company recognizes in earnings each period the changes in carrying values of these foreign currency denominated assets and
11


liabilities due to changes in exchange rates. The changes in fair values of the cross-currency swap derivatives are recorded in AOCI with an immediate reclassification into earnings for the changes in fair values attributable to fluctuations in foreign currency exchange rates. The total notional values of derivatives that were designated as cash flow hedges for the Company’s foreign currency denominated assets and liabilities were $1,524 million and $1,994 million as of April 1, 2022 and December 31, 2021.
The Company has entered into commodity futures contracts and other derivative instruments on various commodities to mitigate the price risk associated with forecasted purchases of materials used in our manufacturing process. These derivative instruments were designated as part of the Company’s commodity cash flow hedging program. The objective of this hedging program is to reduce the variability of cash flows associated with future purchases of certain commodities. The total notional value of derivatives that were designated and qualified for this program was $10 million as of December 31, 2021. As of April 1, 2022, we did not have any commodity futures contracts nor other derivative instruments on various commodities designated as a cash flow hedge.
Our Company monitors our mix of short-term debt and long-term debt regularly. We manage our risk to interest rate fluctuations through the use of derivative financial instruments. From time to time, the Company enters into interest rate swap agreements and designates these instruments as part of the Company’s interest rate cash flow hedging program. The objective of this hedging program is to mitigate the risk of adverse changes in benchmark interest rates on the Company’s future interest payments. As of April 1, 2022 and December 31, 2021, we did not have any interest rate swaps designated as a cash flow hedge.
The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on other comprehensive income (“OCI”), AOCI and earnings (in millions):
Gain (Loss)
Recognized
in OCI
Location of Gain (Loss) Recognized in Income Gain (Loss) Reclassified from AOCI into Income
Three Months Ended April 1, 2022
Foreign currency contracts $ 81  Net operating revenues $ 8 
Foreign currency contracts 6  Cost of goods sold 1 
Foreign currency contracts   Interest expense (1)
Foreign currency contracts (5) Other income (loss) — net (11)
Total $ 82  $ (3)
Three Months Ended April 2, 2021
Foreign currency contracts $ (23) Net operating revenues $ (23)
Foreign currency contracts (5) Cost of goods sold (1)
Foreign currency contracts —  Interest expense (1)
Foreign currency contracts 87  Other income (loss) — net 66 
Interest rate contracts 121  Interest expense (5)
Total
$ 180    $ 36 
As of April 1, 2022, the Company estimates that it will reclassify into earnings during the next 12 months net gains of $93 million from the pretax amount recorded in AOCI as the anticipated cash flows occur.
Fair Value Hedging Strategy
The Company uses interest rate swap agreements designated as fair value hedges to minimize exposure to changes in the fair value of fixed-rate debt that result from fluctuations in benchmark interest rates. The Company also uses cross-currency interest rate swaps to hedge the changes in the fair value of foreign currency denominated debt relating to fluctuations in foreign currency exchange rates and benchmark interest rates. The changes in the fair values of derivatives designated as fair value hedges and the offsetting changes in the fair values of the hedged items are recognized in earnings. As a result, any difference is reflected in earnings as ineffectiveness. When a derivative is no longer designated as a fair value hedge for any reason, including termination and maturity, the remaining unamortized difference between the carrying value of the hedged item at that time and the face value of the hedged item is amortized to earnings over the remaining life of the hedged item, or immediately if the hedged item has matured or has been extinguished. The total notional values of derivatives that were designated and qualified as fair value hedges of this type were $11,717 million and $12,113 million as of April 1, 2022 and December 31, 2021, respectively.
12


The following table summarizes the pretax impact that changes in the fair values of derivatives designated as fair value hedges had on earnings (in millions):
Hedging Instruments and Hedged Items Location of Gain (Loss) Recognized in Income Gain (Loss)
Recognized in Income
Three Months Ended
April 1,
2022
April 2,
2021
Interest rate contracts Interest expense $ (711) $ (395)
Fixed-rate debt Interest expense 709  396 
Net impact to interest expense   $ (2) $
Net impact of fair value hedging instruments $ (2) $
The following table summarizes the amounts recorded in our consolidated balance sheets related to hedged items in fair value hedging relationships (in millions):
Cumulative Amount of Fair Value Hedging Adjustments1
Carrying Values of
Hedged Items
Included in the Carrying Values of Hedged Items Remaining for Which Hedge Accounting Has Been Discontinued
Balance Sheet Location of Hedged Items April 1,
2022
December 31,
2021
April 1,
2022
December 31,
2021
April 1,
2022
December 31,
2021
Current maturities of long-term debt $   $ 200  $   $ $   $ — 
Long-term debt 11,443  12,353  (445) 255  220  228 
1Cumulative amount of fair value hedging adjustments does not include changes due to foreign currency exchange rate fluctuations.
Hedges of Net Investments in Foreign Operations Strategy
The Company uses forward contracts and a portion of its foreign currency denominated debt, a non-derivative financial instrument, to protect the value of our net investments in a number of foreign operations. For derivative financial instruments that are designated and qualify as hedges of net investments in foreign operations, the changes in the fair values of the derivative financial instruments are recognized in net foreign currency translation adjustments, a component of AOCI, to offset the changes in the values of the net investments being hedged. For non-derivative financial instruments that are designated and qualify as hedges of net investments in foreign operations, the changes in the carrying values of the designated portions of the non-derivative financial instruments due to fluctuations in foreign currency exchange rates are recorded in net foreign currency translation adjustments. Any ineffective portions of net investment hedges are reclassified from AOCI into earnings during the period of change.
The following table summarizes the notional values and pretax impact of changes in the fair values of instruments designated as net investment hedges (in millions):
Notional Values Gain (Loss) Recognized in OCI
as of Three Months Ended
  April 1,
2022
December 31,
2021
April 1,
2022
April 2,
2021
Foreign currency contracts $ 54  $ 40  $ (6) $ (8)
Foreign currency denominated debt 12,457  12,812  355  483 
Total $ 12,511  $ 12,852  $ 349  $ 475 
The Company did not reclassify any gains or losses related to net investment hedges from AOCI into earnings during the three months ended April 1, 2022 and April 2, 2021. In addition, the Company did not have any ineffectiveness related to net investment hedges during the three months ended April 1, 2022 and April 2, 2021. The cash inflows and outflows associated with the Company’s derivative contracts designated as net investment hedges are classified in the line item other investing activities in our consolidated statement of cash flows.
13


Economic (Non-Designated) Hedging Strategy
In addition to derivative instruments that are designated and qualify for hedge accounting, the Company also uses certain derivatives as economic hedges of foreign currency, interest rate and commodity exposure. Although these derivatives were not designated and/or did not qualify for hedge accounting, they are effective economic hedges. The changes in the fair values of economic hedges are immediately recognized in earnings.
The Company uses foreign currency economic hedges to offset the earnings impact that fluctuations in foreign currency exchange rates have on certain monetary assets and liabilities denominated in nonfunctional currencies. The changes in the fair values of economic hedges used to offset those monetary assets and liabilities are immediately recognized in earnings in the line item other income (loss) — net in our consolidated statement of income. In addition, we use foreign currency economic hedges to minimize the variability in cash flows associated with fluctuations in foreign currency exchange rates, including those related to certain acquisition and divestiture activities. The changes in the fair values of economic hedges used to offset the variability in U.S. dollar net cash flows are immediately recognized in earnings in the line items net operating revenues, cost of goods sold or other income (loss) — net in our consolidated statement of income, as applicable. The total notional values of derivatives related to our foreign currency economic hedges were $5,623 million and $4,258 million as of April 1, 2022 and December 31, 2021, respectively.
The Company uses interest rate contracts as economic hedges to minimize exposure to changes in the fair value of fixed-rate debt that result from fluctuations in benchmark interest rates. The total notional value of derivatives related to our economic hedges of this type was $200 million as of December 31, 2021. As of April 1, 2022, we did not have any interest rate contracts used as economic hedges.
The Company also uses certain derivatives as economic hedges to mitigate the price risk associated with the purchase of materials used in the manufacturing process and vehicle fuel. The changes in the fair values of these economic hedges are immediately recognized in earnings in the line items net operating revenues, cost of goods sold, or selling, general and administrative expenses in our consolidated statement of income, as applicable. The total notional values of derivatives related to our economic hedges of this type were $859 million and $908 million as of April 1, 2022 and December 31, 2021, respectively.
The following table presents the pretax impact that changes in the fair values of derivatives not designated as hedging instruments had on earnings (in millions):
Derivatives Not Designated as Hedging Instruments Location of Gain (Loss) Recognized in Income Gain (Loss)
Recognized in Income
Three Months Ended
April 1,
2022
April 2,
2021
Foreign currency contracts Net operating revenues $ (15) $ (1)
Foreign currency contracts Cost of goods sold 13  (8)
Foreign currency contracts Other income (loss) — net 42  (28)
Interest rate contracts Interest expense   (187)
Commodity contracts Cost of goods sold 160  82 
Other derivative instruments Selling, general and administrative expenses (3)
Other derivative instruments Other income (loss) — net   (3)
Total   $ 197  $ (137)
NOTE 7: DEBT AND BORROWING ARRANGEMENTS
During the three months ended April 1, 2022, the Company retired upon maturity fixed interest rate U.S. dollar-denominated debentures of $288 million with an interest rate of 8.500 percent.
NOTE 8: COMMITMENTS AND CONTINGENCIES
Guarantees
As of April 1, 2022, we were contingently liable for guarantees of indebtedness owed by third parties of $567 million, of which $87 million was related to variable interest entities. Our guarantees are primarily related to third-party customers, bottlers and vendors and have arisen through the normal course of business. These guarantees have various terms, and none of these guarantees is individually significant. These amounts represent the maximum potential future payments that we could be required to make under the guarantees. However, management has concluded that the likelihood of any significant amounts being paid by our Company under these guarantees is not probable.
14


We believe our exposure to concentrations of credit risk is limited due to the diverse geographic areas covered by our operations.
Legal Contingencies
The Company is involved in various legal proceedings. We establish reserves for specific legal proceedings when we determine that the likelihood of an unfavorable outcome is probable and the amount of loss can be reasonably estimated. Management has also identified certain other legal matters where we believe an unfavorable outcome is reasonably possible and/or for which no estimate of possible losses can be made. Management believes that the total liabilities of the Company that may arise as a result of currently pending legal proceedings (excluding tax audit claims) will not have a material adverse effect on the Company taken as a whole.
Tax Audits
The Company is involved in various tax matters, with respect to some of which the outcome is uncertain. We establish reserves to remove some or all of the tax benefit of any of our tax positions at the time we determine that it becomes uncertain based upon one of the following conditions: (1) the tax position is not “more likely than not” to be sustained; (2) the tax position is “more likely than not” to be sustained but for a lesser amount; or (3) the tax position is “more likely than not” to be sustained but not in the financial period in which the tax position was originally taken. For purposes of evaluating whether or not a tax position is uncertain, (1) we presume the tax position will be examined by the relevant taxing authority that has full knowledge of all relevant information; (2) the technical merits of a tax position are derived from authorities, such as legislation and statutes, legislative intent, regulations, rulings and caselaw and their applicability to the facts and circumstances of the tax position; and (3) each tax position is evaluated without consideration of the possibility of offset or aggregation with other tax positions taken. A number of years may elapse before a particular uncertain tax position is audited and finally resolved. The number of years subject to tax audits or tax assessments varies depending on the tax jurisdiction. The tax benefit that has been previously reserved because of a failure to meet the “more likely than not” recognition threshold would be recognized in income tax expense in the quarter in which the uncertainty disappears under any one of the following conditions: (1) the tax position is “more likely than not” to be sustained; (2) the tax position, amount, and/or timing is ultimately settled through negotiation or litigation; or (3) the statute of limitations for the tax position has expired. Refer to Note 14.
On September 17, 2015, the Company received a Statutory Notice of Deficiency (“Notice”) from the U.S. Internal Revenue Service (“IRS”) seeking approximately $3.3 billion of additional federal income tax for years 2007 through 2009. In the Notice, the IRS stated its intent to reallocate over $9 billion of income to the U.S. parent company from certain of its foreign affiliates that the U.S. parent company licensed to manufacture, distribute, sell, market and promote its products in certain non-U.S. markets.
The Notice concerned the Company’s transfer pricing between its U.S. parent company and certain of its foreign affiliates. IRS rules governing transfer pricing require arm’s-length pricing of transactions between related parties such as the Company’s U.S. parent and its foreign affiliates.
To resolve the same transfer pricing issue for the tax years 1987 through 1995, the Company and the IRS had agreed in 1996 on an arm’s-length methodology for determining the amount of U.S. taxable income that the U.S. parent company would report as compensation from its foreign licensees. The Company and the IRS memorialized this accord in a closing agreement resolving that dispute (“Closing Agreement”). The Closing Agreement provided that, absent a change in material facts or circumstances or relevant federal tax law, in calculating the Company’s income taxes going forward, the Company would not be assessed penalties by the IRS for using the agreed-upon tax calculation methodology that the Company and the IRS agreed would be used for the 1987 through 1995 tax years.
The IRS audited and confirmed the Company’s compliance with the agreed-upon Closing Agreement methodology in five successive audit cycles for tax years 1996 through 2006.
The September 17, 2015 Notice from the IRS retroactively rejected the previously agreed-upon methodology for the 2007 through 2009 tax years in favor of an entirely different methodology, without prior notice to the Company. Using the new tax calculation methodology, the IRS reallocated over $9 billion of income to the U.S. parent company from its foreign licensees for tax years 2007 through 2009. Consistent with the Closing Agreement, the IRS did not assert penalties, and it has yet to do so.
The IRS designated the Company’s matter for litigation on October 15, 2015. Litigation designation is an IRS determination that forecloses to a company any and all alternative means for resolution of a tax dispute. As a result of the IRS’ designation of the Company’s matter for litigation, the Company was forced to either accept the IRS’ newly imposed tax assessment and pay the full amount of the asserted tax or litigate the matter in the federal courts. The matter remains subject to the IRS’ litigation designation, preventing the Company from any attempt to settle or otherwise mutually resolve the matter with the IRS.
15


The Company consequently initiated litigation by filing a petition in the U.S. Tax Court (“Tax Court”) in December 2015, challenging the tax adjustments enumerated in the Notice.
Prior to trial, the IRS increased its transfer pricing adjustment by $385 million, resulting in an additional tax adjustment of $135 million. The Company obtained a summary judgment in its favor on a different matter related to Mexican foreign tax credits, which thereafter effectively reduced the IRS’ potential tax adjustment by approximately $138 million.
The trial was held in the Tax Court from March through May 2018, and final post-trial briefs were filed and exchanged in April 2019.
On November 18, 2020, the Tax Court issued an opinion (“Opinion”) in which it predominantly sided with the IRS but agreed with the Company that dividends previously paid by the foreign licensees to the U.S. parent company in reliance upon the Closing Agreement should continue to be allowed to offset royalties, including those that would become payable to the Company in accordance with the Opinion. The Tax Court reserved ruling on the effect of Brazilian legal restrictions on the payment of royalties by the Company’s licensee in Brazil until after the Tax Court issues its opinion in the separate case of 3M Co. & Subs. v. Commissioner, T.C. Docket No. 5816-13 (filed March 11, 2013). Once the Tax Court issues its opinion in 3M Co. & Subs. v. Commissioner, the Company expects the Tax Court thereafter to render another opinion, and ultimately a final decision, in the Company’s case.
The Company believes that the IRS and the Tax Court misinterpreted and misapplied the applicable regulations in reallocating income earned by the Company’s foreign licensees to increase the Company’s U.S. tax. Moreover, the Company believes that the retroactive imposition of such tax liability using a calculation methodology different from that previously agreed upon by the IRS and the Company, and audited by the IRS for over a decade, is unconstitutional. The Company intends to assert its claims on appeal and vigorously defend its position.
In determining the amount of tax reserve to be recorded as of December 31, 2020, the Company completed the required two-step evaluation process prescribed by Accounting Standards Codification 740, Accounting for Income Taxes. In doing so, we consulted with outside advisors and we reviewed and considered relevant laws, rules, and regulations, including, but not limited to, the Opinion and relevant caselaw. We also considered our intention to vigorously defend our positions and assert our various well-founded legal claims via every available avenue of appeal. We concluded, based on the technical and legal merits of the Company’s tax positions, that it is more likely than not the Company’s tax positions will ultimately be sustained on appeal. In addition, we considered a number of alternative transfer pricing methodologies, including the methodology asserted by the IRS and affirmed in the Opinion (“Tax Court Methodology”), that could be applied by the courts upon final resolution of the litigation. Based on the required probability analysis, we determined the methodologies we believe the federal courts could ultimately order to be used in calculating the Company’s tax. As a result of this analysis, we recorded a tax reserve of $438 million during the year ended December 31, 2020 related to the application of the resulting methodologies as well as the different tax treatment applicable to dividends originally paid to the U.S. parent company by its foreign licensees, in reliance upon the Closing Agreement, that would be recharacterized as royalties in accordance with the Opinion and the Company’s analysis.
The Company’s conclusion that it is more likely than not the Company’s tax positions will ultimately be sustained on appeal is unchanged as of April 1, 2022. However, we updated our calculation of the methodologies we believe the federal courts could ultimately order to be used in calculating the Company’s tax. As a result of the application of the required probability analysis to these updated calculations and the accrual of interest through the current reporting period, we updated our tax reserve as of April 1, 2022 to $410 million.
While the Company strongly disagrees with the IRS’ positions and the portions of the Opinion affirming such positions, it is possible that some portion or all of the adjustment proposed by the IRS and sustained by the Tax Court could ultimately be upheld. In that event, the Company would likely be subject to significant additional liabilities for tax years 2007 through 2009, and potentially also for subsequent years, which could have a material adverse impact on the Company’s financial position, results of operations and cash flows.
The Company calculated the potential impact of applying the Tax Court Methodology to reallocate income from foreign licensees potentially covered within the scope of the Opinion, assuming such methodology were to be ultimately upheld by the courts, and the IRS were to decide to apply that methodology to subsequent years, with consent of the federal courts. This impact would include taxes and interest accrued through December 31, 2021 for the 2007 through 2009 litigated tax years and for subsequent tax years from 2010 through 2021. The calculations incorporated the estimated impact of correlative adjustments to the previously accrued transition tax payable under the 2017 Tax Cuts and Jobs Act. The Company estimates that the potential aggregate incremental tax and interest liability could be approximately $13 billion as of December 31, 2021. Additional income tax and interest would continue to accrue until the time any such potential liability, or portion thereof, were to be paid. The Company estimates the impact of the continued application of the Tax Court Methodology for the three months ended April 1, 2022 would increase the potential aggregate incremental tax and interest liability by approximately $250 million. Additionally, we currently project the continued application of the Tax Court Methodology in future years, assuming similar
16


facts and circumstances as of December 31, 2021, would result in an incremental annual tax liability that would increase the Company’s effective tax rate by approximately 3.5 percent.
The Company does not know when the Tax Court will issue its opinion regarding the effect of Brazilian legal restrictions on the payment of royalties by the Company’s licensee in Brazil for the 2007 through 2009 tax years. After the Tax Court issues its opinion on the Company’s Brazilian licensee, the Company and the IRS will be provided time to agree on the tax impact, if any, of both opinions, after which the Tax Court would render a final decision in the case. The Company will have 90 days thereafter to file a notice of appeal to the U.S. Court of Appeals for the Eleventh Circuit and pay the tax liability and interest related to the 2007 through 2009 tax years. The Company currently estimates that the payment to be made at that time related to the 2007 through 2009 tax years, which is included in the above estimate of the potential aggregate incremental tax and interest liability, would be approximately $5.0 billion (including interest accrued through April 1, 2022), plus any additional interest accrued through the time of payment. Some or all of this amount would be refunded if the Company were to prevail on appeal.
Risk Management Programs
The Company has numerous global insurance programs in place to help protect the Company from the risk of loss. In general, we are self-insured for large portions of many different types of claims; however, we do use commercial insurance above our self-insured retentions to reduce the Company’s risk of catastrophic loss. Our reserves for the Company’s self-insured losses are estimated using actuarial methods and assumptions of the insurance industry, adjusted for our specific expectations based on our claims history. Our self-insurance reserves totaled $228 million and $229 million as of April 1, 2022 and December 31, 2021, respectively.
NOTE 9: OTHER COMPREHENSIVE INCOME
AOCI attributable to shareowners of The Coca-Cola Company is separately presented in our consolidated balance sheet as a component of The Coca-Cola Company’s shareowners’ equity, which also includes our proportionate share of equity method investees’ AOCI. OCI attributable to noncontrolling interests is allocated to, and included in, our consolidated balance sheet as part of the line item equity attributable to noncontrolling interests.
AOCI attributable to shareowners of The Coca-Cola Company consisted of the following, net of tax (in millions):
April 1,
2022
December 31,
2021
Net foreign currency translation adjustments $ (11,719) $ (12,595)
Accumulated net gains (losses) on derivatives 84  20 
Unrealized net gains (losses) on available-for-sale debt securities (97) (62)
Adjustments to pension and other postretirement benefit liabilities (1,608) (1,693)
Accumulated other comprehensive income (loss) $ (13,340) $ (14,330)
The following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions):
Three Months Ended April 1, 2022
Shareowners of
The Coca-Cola Company
Noncontrolling
Interests
Total
Consolidated net income $ 2,781  $ 12  $ 2,793 
Other comprehensive income:
Net foreign currency translation adjustments 876  133  1,009 
Net gains (losses) on derivatives1
64  —  64 
Net change in unrealized gains (losses) on available-for-sale debt securities2
(35) —  (35)
Net change in pension and other postretirement benefit liabilities 85  —  85 
Total comprehensive income (loss) $ 3,771  $ 145  $ 3,916 
1Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
2Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
17


The following tables present OCI attributable to shareowners of The Coca-Cola Company, including our proportionate share of equity method investees’ OCI (in millions):
Three Months Ended April 1, 2022 Before-Tax Amount Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period $ 1,324  $ (240) $ 1,084 
Reclassification adjustments recognized in net income 200  —  200 
Gains (losses) on intra-entity transactions that are of a long-term investment nature (670) —  (670)
Gains (losses) on net investment hedges arising during the period1
349  (87) 262 
Net foreign currency translation adjustments $ 1,203  $ (327) $ 876 
Derivatives:
Gains (losses) arising during the period $ 83  $ (21) $ 62 
Reclassification adjustments recognized in net income (1)
Net gains (losses) on derivatives1
$ 86  $ (22) $ 64 
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period $ (46) $ $ (38)
Reclassification adjustments recognized in net income (1)
Net change in unrealized gains (losses) on available-for-sale debt securities2
$ (42) $ $ (35)
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period $ 68  $ (4) $ 64 
Reclassification adjustments recognized in net income 28  (7) 21 
Net change in pension and other postretirement benefit liabilities $ 96  $ (11) $ 85 
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
   Company
$ 1,343  $ (353) $ 990 
1Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
2Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
Three Months Ended April 2, 2021 Before-Tax Amount Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period $ 624  $ (23) $ 601 
Gains (losses) on intra-entity transactions that are of a long-term investment nature (954) —  (954)
Gains (losses) on net investment hedges arising during the period1
475  (118) 357 
Net foreign currency translation adjustments $ 145  $ (141) $
Derivatives:
Gains (losses) arising during the period $ 174  $ (43) $ 131 
Reclassification adjustments recognized in net income (36) (27)
Net gains (losses) on derivatives1
$ 138  $ (34) $ 104 
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period $ (92) $ 30  $ (62)
Reclassification adjustments recognized in net income (1)
Net change in unrealized gains (losses) on available-for-sale debt securities2
$ (89) $ 29  $ (60)
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period $ 453  $ (109) $ 344 
Reclassification adjustments recognized in net income 101  (25) 76 
Net change in pension and other postretirement benefit liabilities $ 554  $ (134) $ 420 
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
   Company
$ 748  $ (280) $ 468 
1Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
2Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
18


The following table presents the amounts and line items in our consolidated statement of income where adjustments reclassified from AOCI into income were recorded (in millions):
Amount Reclassified from AOCI into Income
Description of AOCI Component Financial Statement Line Item Three Months Ended April 1, 2022
Foreign currency translation adjustments:
Divestitures, deconsolidations and other1
Other income (loss) — net $ 200 
Income before income taxes 200 
Income taxes — 
Consolidated net income $ 200 
Derivatives:
Foreign currency contracts Net operating revenues $ (8)
Foreign currency contracts Cost of goods sold (1)
Foreign currency contracts Interest expense
Foreign currency contracts Other income (loss) — net 11 
Income before income taxes
Income taxes (1)
Consolidated net income $
Available-for-sale debt securities:
Sale of debt securities Other income (loss) — net $
Income before income taxes
Income taxes (1)
Consolidated net income $
Pension and other postretirement benefit liabilities:
Recognized net actuarial loss Other income (loss) — net $ 29 
Recognized prior service cost (credit) Other income (loss) — net (1)
Income before income taxes 28 
Income taxes (7)
Consolidated net income $ 21 
1Related to the sale of our ownership interest in one of our equity method investments and the issuance of additional shares of stock by one of our equity method investees. Refer to Note 2 and Note 15, respectively.
19


NOTE 10: CHANGES IN EQUITY
The following tables provide a reconciliation of the beginning and ending carrying amounts of total equity, equity attributable to shareowners of The Coca-Cola Company and equity attributable to noncontrolling interests (in millions):
 
Shareowners of The Coca-Cola Company  
 
Three Months Ended April 1, 2022 Common Shares Outstanding Total Reinvested Earnings Accumulated Other Comprehensive Income (Loss) Common Stock Capital Surplus Treasury Stock Non-controlling Interests
December 31, 2021 4,325  $ 24,860  $ 69,094  $ (14,330) $ 1,760  $ 18,116  $ (51,641) $ 1,861 
Comprehensive income (loss) —  3,916  2,781  990  —  —  —  145 
Dividends paid/payable to
  shareowners of The Coca-Cola
  Company ($0.44 per share)
—  (1,906) (1,906) —  —  —  —  — 
Dividends paid to noncontrolling
  interests
—  (9) —  —  —  —  —  (9)
Acquisition of interests held by
  noncontrolling owners
—  (1) —  —  —  —  —  (1)
Purchases of treasury stock (8) (471) —  —  —  —  (471) — 
Impact related to stock-based
  compensation plans
14  451  —  —  —  271  180  — 
Other activities —  —  —  —  —  — 
April 1, 2022 4,331  $ 26,841  $ 69,969  $ (13,340) $ 1,760  $ 18,388  $ (51,932) $ 1,996 
 
Shareowners of The Coca-Cola Company  
 
Three Months Ended April 2, 2021 Common Shares Outstanding Total Reinvested Earnings Accumulated Other Comprehensive Income (Loss) Common Stock Capital Surplus Treasury Stock Non-controlling Interests
December 31, 2020 4,302  $ 21,284  $ 66,555  $ (14,601) $ 1,760  $ 17,601  $ (52,016) $ 1,985 
Adoption of accounting standards1
—  19  19  —  —  —  —  — 
Comprehensive income (loss) —  2,723  2,245  468  —  —  —  10 
Dividends paid/payable to
   shareowners of The Coca-Cola
   Company ($0.42 per share)
—  (1,810) (1,810) —  —  —  —  — 
Dividends paid to noncontrolling
   interests
—  (18) —  —  —  —  —  (18)
Impact related to stock-based
   compensation plans
134  —  —  —  29  105  — 
April 2, 2021 4,311  $ 22,332  $ 67,009  $ (14,133) $ 1,760  $ 17,630  $ (51,911) $ 1,977 
1Represents the adoption of Accounting Standards Update 2019-12, Simplifying the Accounting for Income Taxes, effective January 1, 2021.
NOTE 11: SIGNIFICANT OPERATING AND NONOPERATING ITEMS
Other Operating Charges
During the three months ended April 1, 2022, the Company recorded other operating charges of $28 million. These charges primarily consisted of $22 million related to the remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife, LLC (“fairlife”) in 2020, $10 million related to the Company’s productivity and reinvestment program and $2 million related to the restructuring of our manufacturing operations in the United States. These charges were partially offset by a net gain of $5 million, which included the reimbursement of distributor termination fees for BA Sports Nutrition, LLC (“BodyArmor”) recorded in the prior year partially offset by various transition and transaction costs, employee retention costs and the amortization of noncompete agreements, and income of $1 million related to the Company’s strategic realignment initiatives primarily as a result of a revision to estimated severance costs accrued in the prior year.
During the three months ended April 2, 2021, the Company recorded other operating charges of $124 million. These charges primarily consisted of $93 million related to the Company’s strategic realignment initiatives and $18 million related to the Company’s productivity and reinvestment program. In addition, other operating charges included $4 million related to the remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition and $9 million related to tax litigation expense.
20


Refer to Note 8 for additional information related to the tax litigation. Refer to Note 12 for additional information on the Company’s productivity and reinvestment program. Refer to Note 15 for additional information on the fairlife acquisition. Refer to Note 16 for the impact these charges had on our operating segments and Corporate.
Other Nonoperating Items
Interest Expense
During the three months ended April 2, 2021, the Company recorded charges of $58 million related to the extinguishment of long-term debt.
Equity Income (Loss) — Net
During the three months ended April 1, 2022 and April 2, 2021, the Company recorded net gains of $5 million and $37 million, respectively. These amounts represent the Company’s proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees.
Other Income (Loss) — Net
During the three months ended April 1, 2022, the Company recorded a net loss of $104 million related to realized and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities and a net loss of $24 million as a result of one of our equity method investees issuing additional shares of its stock.
During the three months ended April 2, 2021, the Company recognized a net gain of $133 million related to realized and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities. The Company also recorded pension settlement charges of $54 million related to our strategic realignment initiatives.
Refer to Note 4 for additional information on equity and debt securities. Refer to Note 15 for additional information on one of our equity method investees issuing additional shares of its stock. Refer to Note 16 for the impact these items had on our operating segments and Corporate.
NOTE 12: RESTRUCTURING
In February 2012, the Company announced a productivity and reinvestment program designed to strengthen our brands and reinvest our resources to drive long-term profitable growth. The program was expanded multiple times, with the last expansion occurring in April 2017. While we expect most of the remaining initiatives included in this program, which are primarily designed to further simplify and standardize our organization, to be completed by the end of 2023, certain initiatives may extend into 2024.
During the three months ended April 1, 2022 and April 2, 2021, the Company incurred expenses of $10 million and $18 million, respectively, related to our productivity and reinvestment program. These expenses primarily included internal and external costs associated with the implementation of these initiatives and were recorded in the line item other operating charges in our consolidated statements of income. Refer to Note 16 for the impact these expenses had on our operating segments and Corporate. The Company has incurred total pretax expenses of $4,054 million related to this program since it commenced.
21


NOTE 13: PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
Net periodic benefit cost or income for our pension and other postretirement benefit plans consisted of the following (in millions):
Pension Plans Other Postretirement
Benefit Plans
Three Months Ended
April 1,
2022
April 2,
2021
April 1,
2022
April 2,
2021
Service cost $ 22  $ 24  $ 2  $
Interest cost 51  44  4 
Expected return on plan assets1
(149) (151) (4) (4)
Amortization of prior service credit   —  (1) (1)
Amortization of net actuarial loss 29  47   
Net periodic benefit cost (income) (47) (36) 1 
Settlement charges2
  54  —  — 
Total cost (income) $ (47) $ 18  $ 1  $
1The weighted-average expected long-term rates of return on plan assets used in computing 2022 net periodic benefit cost (income) were 7.00 percent for pension plans and 4.00 percent for other postretirement benefit plans.
2Settlement charges were primarily related to our strategic realignment initiatives.
All of the amounts in the table above, other than service cost, were recorded in the line item other income (loss) — net in our consolidated statements of income. During the three months ended April 1, 2022, the Company contributed $3 million to our pension trusts, and we anticipate making additional contributions of approximately $24 million during the remainder of 2022. The Company contributed $5 million to our pension trusts during the three months ended April 2, 2021.
NOTE 14: INCOME TAXES
The Company recorded income taxes of $665 million (19.2 percent effective tax rate) and $508 million (18.4 percent effective tax rate) during the three months ended April 1, 2022 and April 2, 2021, respectively.
The Company’s effective tax rates for the three months ended April 1, 2022 and April 2, 2021 vary from the statutory U.S. federal income tax rate of 21.0 percent primarily due to the tax impact of significant operating and nonoperating items, as described in Note 11, along with the tax benefits of having significant earnings generated outside the United States and significant earnings generated in investments accounted for under the equity method, both of which are generally taxed at rates lower than the statutory U.S. rate.
On November 18, 2020, the Tax Court issued the Opinion regarding the Company’s 2015 litigation with the IRS involving transfer pricing tax adjustments in which the court predominantly sided with the IRS. The Company strongly disagrees with the Opinion and intends to vigorously defend its position. Refer to Note 8.
NOTE 15: FAIR VALUE MEASUREMENTS
Recurring Fair Value Measurements
The following tables summarize assets and liabilities measured at fair value on a recurring basis (in millions):
April 1, 2022 Level 1 Level 2 Level 3
Other3
Netting
Adjustment
4
Fair Value
Measurements
Assets:          
Equity securities with readily determinable values1
$ 2,258  $ 220  $ 16  $ 101  $ —  $ 2,595 
Debt securities1
—  1,822  11 

—  —  1,833 
Derivatives2
154  510  —  —  (432)
6
232 
8
Total assets $ 2,412  $ 2,552  $ 27  $ 101  $ (432) $ 4,660 
Liabilities:          
Contingent consideration liability $ —  $ —  $ 612 
5
$ —  $ —  $ 612 
Derivatives2
—  592  —  —  (580)
7
12 
8
Total liabilities $ —  $ 592  $ 612  $ —  $ (580) $ 624 
22


1Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt securities.
2Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
3Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 4.
4Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 6.
5Represents the fair value of future milestone payments related to our acquisition of fairlife in 2020, which are contingent on fairlife achieving certain financial targets through 2024 and, if achieved, are payable in 2023 and 2025. These milestone payments are based on agreed-upon formulas related to fairlife’s operating results, the resulting values of which are not subject to a ceiling.
6The Company is obligated to return $70 million in cash collateral it has netted against its derivative positions.
7The Company has the right to reclaim $344 million in cash collateral it has netted against its derivative positions.
8The Company’s derivative financial instruments are recorded at fair value in our consolidated balance sheet as follows: $137 million in the line item prepaid expenses and other current assets, $95 million in the line item other noncurrent assets and $12 million in the line item other noncurrent liabilities. Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
December 31, 2021 Level 1 Level 2 Level 3
Other3
Netting
Adjustment
4
Fair Value
Measurements
Assets:  
 
     
Equity securities with readily determinable values1
$ 2,372  $ 230  $ 17  $ 104  $ —  $ 2,723 
Debt securities1
—  1,556  33  —  —  1,589 
Derivatives2
69  588  —  —  (459)
6
198 
8
Total assets $ 2,441  $ 2,374  $ 50  $ 104  $ (459) $ 4,510 
Liabilities:          
Contingent consideration liability $ —  $ —  $ 590 
5
$ —  $ —  $ 590 
Derivatives2
—  96  —  —  (82)
7
14 
8
Total liabilities $ —  $ 96  $ 590  $ —  $ (82) $ 604 
1Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt securities.
2Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
3Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 4.
4Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 6.
5Represents the fair value of future milestone payments related to our acquisition of fairlife in 2020, which are contingent on fairlife achieving certain financial targets through 2024 and, if achieved, are payable in 2023 and 2025. These milestone payments are based on agreed-upon formulas related to fairlife’s operating results, the resulting values of which are not subject to a ceiling.
6The Company is obligated to return $331 million in cash collateral it has netted against its derivative positions.
7The Company does not have the right to reclaim any cash collateral it has netted against its derivative positions.
8The Company’s derivative financial instruments are recorded at fair value in our consolidated balance sheet as follows: $198 million in the line item other noncurrent assets and $14 million in the line item other noncurrent liabilities. Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
Gross realized and unrealized gains and losses on Level 3 assets and liabilities were not significant for the three months ended April 1, 2022 and April 2, 2021.
The Company recognizes transfers between levels within the hierarchy as of the beginning of the reporting period. Gross transfers between levels within the hierarchy were not significant for the three months ended April 1, 2022 and April 2, 2021.
23


Nonrecurring Fair Value Measurements
We recognized a net loss of $24 million on assets measured at fair value on a nonrecurring basis during the three months ended April 1, 2022. We did not recognize any gains or losses on assets measured at fair value on a nonrecurring basis during the three months ended April 2, 2021. The net loss in 2022 was recorded as a result of an equity method investee issuing additional shares of its stock. Accordingly, the Company is required to treat this type of transaction as if the Company had sold a proportionate share of its investment. This net loss was determined using Level 2 inputs and primarily resulted from the recognition of cumulative translation losses.
Other Fair Value Disclosures
The carrying values of cash and cash equivalents; short-term investments; trade accounts receivable; accounts payable and accrued expenses; and loans and notes payable approximate their fair values because of the relatively short-term maturities of these financial instruments. The fair value of our long-term debt is estimated using Level 2 inputs based on quoted prices for those instruments. Where quoted prices are not available, the fair value is estimated using discounted cash flows and market-based expectations for interest rates, credit risk and the contractual terms of the debt instruments. As of April 1, 2022, the carrying value and fair value of our long-term debt, including the current portion, were $38,091 million and $36,522 million, respectively. As of December 31, 2021, the carrying value and fair value of our long-term debt, including the current portion, were $39,454 million and $40,311 million, respectively.
NOTE 16: OPERATING SEGMENTS
Information about our Company’s operations by operating segment and Corporate is as follows (in millions):
Europe, Middle East & Africa Latin
America
North
America
Asia Pacific Global Ventures Bottling
Investments
Corporate Eliminations Consolidated
As of and for the Three Months Ended April 1, 2022                
Net operating revenues:                
Third party $ 1,661  $ 1,214  $ 3,589  $ 1,231  $ 729  $ 2,042  $ 25  $   $ 10,491 
Intersegment 172    1  180    2    (355)  
Total net operating revenues 1,833  1,214  3,590  1,411  729  2,044  25  (355) 10,491 
Operating income (loss) 1,007  760  1,056  664  51  193  (326)   3,405 
Income (loss) before income taxes 1,023  757  1,064  670  56  393  (505)   3,458 
Identifiable operating assets 8,092 
2
1,988  26,395  2,574 
3
7,755  10,710 
2,3
17,564    75,078 
Investments1
415  633  19  232    13,193  4,494    18,986 
As of and for the Three Months Ended April 2, 2021                
Net operating revenues:                
Third party $ 1,462  $ 909  $ 2,936  $ 1,232  $ 570  $ 1,894  $ 17  $ —  $ 9,020 
Intersegment 161  —  170  —  —  (334) — 
Total net operating revenues 1,623  909  2,937  1,402  570  1,896  17  (334) 9,020 
Operating income (loss) 820  552  792  686  26  141  (295) —  2,722 
Income (loss) before income taxes 830  555  816  695  27  317  (477) —  2,763 
Identifiable operating assets 8,335 
2
1,650  19,792  2,332 
3
7,843  10,426 
2,3
19,843  —  70,221 
Investments1
466  595  343  249  13,833  4,282  —  19,772 
As of December 31, 2021                
Identifiable operating assets $ 7,908 
2
$ 1,720  $ 25,730  $ 2,355 
3
$ 7,949  $ 10,312 
2,3
$ 19,964  $ —  $ 75,938 
Investments1
436  594  21  230  —  12,669  4,466  —  18,416 
1Principally equity method investments and other investments in bottling companies.
2Property, plant and equipment — net in South Africa represented 17 percent, 15 percent and 16 percent of consolidated property, plant and equipment — net as of April 1, 2022, April 2, 2021 and December 31, 2021, respectively.
3Property, plant and equipment — net in the Philippines represented 10 percent of consolidated property, plant and equipment — net as of April 1, 2022, April 2, 2021 and December 31, 2021.
24


During the three months ended April 1, 2022, the results of our operating segments and Corporate were impacted by the following items:
Operating income (loss) and income (loss) before income taxes were increased by $19 million for North America and were reduced by $14 million for Corporate related to our acquisition of BodyArmor in 2021. Refer to Note 11.
Operating income (loss) and income (loss) before income taxes were reduced by $22 million for Corporate related to the remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition in 2020. Refer to Note 15.
Operating income (loss) and income (loss) before income taxes were reduced by $11 million and $12 million, respectively, for North America related to the restructuring of our manufacturing operations in the United States.
Operating income (loss) and income (loss) before income taxes were reduced by $10 million for Corporate due to the Company’s productivity and reinvestment program. Refer to Note 12.
Income (loss) before income taxes was increased by $5 million for Bottling Investments due to the Company’s proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees.
Income (loss) before income taxes was reduced by $104 million for Corporate related to realized and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities. Refer to Note 4.
Income (loss) before income taxes was reduced by $24 million for Corporate due to one of our equity method investees issuing additional shares of its stock. Refer to Note 15.
During the three months ended April 2, 2021, the results of our operating segments and Corporate were impacted by the following items:
Operating income (loss) and income (loss) before income taxes were reduced by $50 million for Europe, Middle East and Africa, $11 million for Latin America, $12 million for North America and $13 million for Asia Pacific, and operating income (loss) and income (loss) before income taxes were reduced by $7 million and $61 million, respectively, for Corporate due to the Company’s strategic realignment initiatives.
Operating income (loss) and income (loss) before income taxes were reduced by $19 million for North America related to the restructuring of our manufacturing operations in the United States.
Operating income (loss) and income (loss) before income taxes were reduced by $18 million for Corporate due to the Company’s productivity and reinvestment program. Refer to Note 12.
Operating income (loss) and income (loss) before income taxes were reduced by $9 million for Corporate related to tax litigation expense. Refer to Note 8.
Operating income (loss) and income (loss) before income taxes were reduced by $4 million for Corporate related to the remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition. Refer to Note 15.
Income (loss) before income taxes was increased by $133 million for Corporate related to realized and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities. Refer to Note 4.
Income (loss) before income taxes was increased by $5 million for Bottling Investments and $32 million for Corporate due to the Company’s proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees.
Income (loss) before income taxes was reduced by $58 million for Corporate related to charges associated with the extinguishment of long-term debt.
25


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
When used in this report, the terms “The Coca-Cola Company,” “Company,” “we,” “us” and “our” mean The Coca-Cola Company and all entities included in our consolidated financial statements.
On March 8, 2022, the Company announced the suspension of its business in Russia as a result of the conflict between Russia and Ukraine. In addition, the conflict has caused a disruption of our business in Ukraine. Given the rapidly changing conditions, the Company will continue to monitor and assess the situation as circumstances evolve. As a point of reference, in 2021, the Company’s business in Russia and Ukraine contributed approximately 2 percent of the Company’s unit case volume and approximately 1 percent and 2 percent of the Company’s consolidated net operating revenues and operating income, respectively. As of April 1, 2022, the carrying value of the Company’s assets related to Russia and Ukraine is less than
0.5 percent of the Company’s total assets. In addition, as of April 1, 2022, the Company had an approximate 21 percent ownership interest in Coca-Cola HBC AG (“CCH”), the Company’s bottling and distribution partner in the region. If CCH were to record an impairment charge, we would be required to record our proportionate share of the charge as a reduction of equity income (loss) — net in our consolidated statement of income.
During the three months ended April 1, 2022, the effects of the COVID-19 pandemic, including the resurgence of the virus in certain countries and the related actions by governments to attempt to contain the spread of the virus, continued to negatively impact our business. While uncertainties caused by the COVID-19 pandemic remain, and factors such as the state of the supply chain, labor shortages and the inflationary environment are likely to impact the pace of the economic recovery, we expect to continue to see improvements in our business as we continue to learn and adapt to the ever-changing environment.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Recoverability of Current and Noncurrent Assets
Our Company faces many uncertainties and risks related to various economic, political and regulatory environments in the countries in which we operate, particularly in developing and emerging markets. Refer to the headings “Item 1A. Risk Factors” in Part I and “Our Business — Challenges and Risks” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2021. As a result, management must make numerous assumptions, which involve a significant amount of judgment, when performing recoverability and impairment tests of current and noncurrent assets in various regions around the world.
We perform recoverability and impairment tests of current and noncurrent assets in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). For certain assets, recoverability and/or impairment tests are required only when conditions exist that indicate the carrying value may not be recoverable. For other assets, impairment tests are required at least annually, or more frequently if events or circumstances indicate that an asset may be impaired.
The performance of recoverability and impairment tests of current and noncurrent assets involves critical accounting estimates. These estimates require significant management judgment, include inherent uncertainties and are often interdependent; therefore, they do not change in isolation. Factors that management must estimate include, among others, the economic lives of the assets, sales volume, pricing, royalty rates, cost of raw materials, delivery costs, the impact of any supply chain disruptions, inflation, long-term growth rates, cost of capital, marketing spending, foreign currency exchange rates, tax rates, capital spending, proceeds from the sale of assets and customers’ financial condition. The variability of these factors depends on a number of conditions, and thus our accounting estimates may change from period to period. These factors are even more difficult to estimate as a result of uncertainties associated with the conflict in Ukraine and the scope, severity and duration of the global COVID-19 pandemic. The estimates we use when performing recoverability tests of assets are consistent with those we use in our internal planning. When performing impairment tests, we estimate the fair values of the assets using management’s best assumptions, which we believe are consistent with those a market participant would use. While pandemic-related uncertainties still exist, we expect to see continued improvements in our business as consumers return to many of their previous work routines as well as socializing and traveling. The Company has certain intangible and other long-lived assets that are more dependent on cash flows generated in the away-from-home channels and/or that generate cash flows in geographic areas that are more heavily impacted by the COVID-19 pandemic and are therefore more susceptible to impairment. In addition, intangible and other long-lived assets we acquired in recent transactions are naturally more susceptible to impairment, because they are recorded at fair value based on recent operating plans and macroeconomic conditions at the time of acquisition. If we had used other assumptions and estimates when tests of these assets were performed, impairment charges could have resulted. Furthermore, if management uses different assumptions in future periods, or if different conditions exist in future periods, impairment charges could result. The total future impairment charges we may be required to record could be material.
26


As of April 1, 2022, the carrying value of our investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded the fair value by $33 million, or 8 percent. Based on the length of time and the extent to which the fair value has been less than our carrying value and our intent and ability to retain the investment for a period of time sufficient to allow for any anticipated recovery in market value, management determined that the decline in fair value was temporary in nature. Therefore, we did not record an impairment charge related to the investment.
Our equity method investees also perform such recoverability and impairment tests. If an impairment charge is recorded by one of our equity method investees, the Company records its proportionate share of such charge as a reduction of equity income (loss) — net in our consolidated statement of income. However, the actual amount we record with respect to our proportionate share of such charge may be impacted by items such as basis differences, deferred taxes and deferred gains.
OPERATIONS REVIEW
Sales of our ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters typically accounting for the highest sales volumes. The volume of sales in the beverage business may be affected by weather conditions.
Structural Changes, Acquired Brands and Newly Licensed Brands
In order to continually improve upon the Company’s operating performance, from time to time, we engage in buying and selling ownership interests in bottling partners and other manufacturing operations. In addition, we periodically acquire brands and their related operations or enter into license agreements for certain brands to supplement our beverage offerings. These items impact our operating results and certain key metrics used by management in assessing the Company’s performance.
Unit case volume growth is a metric used by management to evaluate the Company’s performance because it measures demand for our products at the consumer level. The Company’s unit case volume represents the number of unit cases (or unit case equivalents) of Company beverage products directly or indirectly sold by the Company and its bottling partners to customers or consumers and, therefore, reflects unit case volume for both consolidated and unconsolidated bottlers. Refer to the heading “Beverage Volume” below.
Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in unit case equivalents) sold by, or used in finished products sold by, the Company to its bottling partners or other customers. For Costa Limited (“Costa”) non-ready-to-drink beverage products, concentrate sales volume represents the amount of beverages, primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the Company to customers or consumers. Refer to the heading “Beverage Volume” below.
When we analyze our net operating revenues, we generally consider the following factors: (1) volume growth (concentrate sales volume or unit case volume, as applicable); (2) changes in price, product and geographic mix; (3) foreign currency fluctuations; and (4) acquisitions and divestitures (including structural changes as defined below), as applicable. Refer to the heading “Net Operating Revenues” below. The Company sells concentrates and syrups to both consolidated and unconsolidated bottling partners. The ownership structure of our bottling partners impacts the timing of recognizing concentrate revenue and concentrate sales volume. When we sell concentrates or syrups to our consolidated bottling partners, we do not recognize the concentrate revenue or concentrate sales volume until the bottling partner has sold finished products manufactured from the concentrates or syrups to a third party. When we sell concentrates or syrups to our unconsolidated bottling partners, we recognize the concentrate revenue and concentrate sales volume when the concentrates or syrups are sold to the bottling partner. The subsequent sale of the finished products manufactured from the concentrates or syrups to a third party does not impact the timing of recognizing the concentrate revenue or concentrate sales volume. When we account for an unconsolidated bottling partner as an equity method investment, we eliminate the intercompany profit related to these transactions to the extent of our ownership interest until the equity method investee has sold finished products manufactured from the concentrates or syrups to a third party. We typically report unit case volume when finished products manufactured from the concentrates or syrups are sold to a third party, regardless of our ownership interest in the bottling partner, if any.
We generally refer to acquisitions and divestitures of bottling operations as “structural changes,” which are a component of acquisitions and divestitures. Typically, structural changes do not impact the Company’s unit case volume or concentrate sales volume on a consolidated basis or at the geographic operating segment level. We recognize unit case volume for all sales of Company beverage products, regardless of our ownership interest in the bottling partner, if any. However, the unit case volume reported by our Bottling Investments operating segment is generally impacted by structural changes because it only includes the unit case volume of our consolidated bottling operations.
“Acquired brands” refers to brands acquired during the past 12 months. Typically, the Company has not reported unit case volume or recognized concentrate sales volume related to acquired brands in periods prior to the closing of a transaction. Therefore, the unit case volume and concentrate sales volume related to an acquired brand are incremental to prior year volume. We generally do not consider the acquisition of a brand to be a structural change.
27


“Licensed brands” refers to brands not owned by the Company but for which we hold certain rights, generally including, but not limited to, distribution rights, and from which we derive an economic benefit when the products are sold. Typically, the Company has not reported unit case volume or recognized concentrate sales volume related to a licensed brand in periods prior to the beginning of the term of a license agreement. Therefore, in the year that a license agreement is entered into, the unit case volume and concentrate sales volume related to a licensed brand are incremental to prior year volume. We generally do not consider the licensing of a brand to be a structural change.
In 2021, the Company acquired the remaining ownership interest in BA Sports Nutrition, LLC (“BodyArmor”). The impact of this acquisition has been included in acquisitions and divestitures in our analysis of net operating revenues on a consolidated basis as well as for the North America operating segment.
Beverage Volume
We measure the volume of Company beverage products sold in two ways: (1) unit cases of finished products and (2) concentrate sales. As used in this report, “unit case” means a unit of measurement equal to 192 U.S. fluid ounces of finished beverage (24 eight-ounce servings), with the exception of unit case equivalents for Costa non-ready-to-drink beverage products, which are primarily measured in number of transactions; and “unit case volume” means the number of unit cases (or unit case equivalents) of Company beverage products directly or indirectly sold by the Company and its bottling partners to customers or consumers. Unit case volume primarily consists of beverage products bearing Company trademarks. Also included in unit case volume are certain brands licensed to, or distributed by, our Company, and brands owned by Coca-Cola system bottlers for which our Company provides marketing support and from the sale of which we derive an economic benefit. In addition, unit case volume includes sales by certain joint ventures in which the Company has an ownership interest. We believe unit case volume is one of the measures of the underlying strength of the Coca-Cola system because it measures trends at the consumer level. The unit case volume numbers used in this report are derived based on estimates received by the Company from its bottling partners and distributors. Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in unit case equivalents) sold by, or used in finished beverages sold by, the Company to its bottling partners or other customers. For Costa non-ready-to-drink beverage products, concentrate sales volume represents the amount of beverages, primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the Company to customers or consumers. Unit case volume and concentrate sales volume growth rates are not necessarily equal during any given period. Factors such as seasonality, bottlers’ inventory practices, supply point changes, timing of price increases, new product introductions and changes in product mix can create differences between unit case volume and concentrate sales volume growth rates. In addition to these items, the impact of unit case volume from certain joint ventures in which the Company has an ownership interest, but to which the Company does not sell concentrates, syrups, source waters or powders/minerals, may give rise to differences between unit case volume and concentrate sales volume growth rates.
Information about our volume growth worldwide and by operating segment is as follows:    
Percent Change 2022 versus 2021
Three Months Ended April 1, 2022
Unit Cases1,2,3
Concentrate Sales4
Worldwide % 11  %
Europe, Middle East & Africa 11  % 15  %
Latin America 20 
North America
Asia Pacific — 
Global Ventures 23  22 
Bottling Investments N/A
1Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only.
2Geographic and Global Ventures operating segment data reflects unit case volume growth for all bottlers, both consolidated and unconsolidated, and distributors in the applicable geographic areas. Global Ventures operating segment data also reflects unit case volume growth for Costa retail stores.
3Unit case volume percent change is based on average daily sales. Unit case volume growth based on average daily sales is computed by comparing the average daily sales in each of the corresponding periods. Average daily sales are the unit cases sold during the period divided by the number of days in the period.
28


4Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in unit case equivalents) sold by, or used in finished beverages sold by, the Company to its bottling partners or other customers and is not based on average daily sales. For Costa non-ready-to-drink beverage products, concentrate sales volume represents the amount of beverages, primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the Company to customers or consumers and is not based on average daily sales. Each of our quarters, other than the fourth quarter, ends on the Friday closest to the last day of the corresponding quarterly calendar period. As a result, the first quarter of 2022 had one less day when compared to the first quarter of 2021, and the fourth quarter of 2022 will have one additional day when compared to the fourth quarter of 2021.
Unit Case Volume
Although a significant portion of our Company’s net operating revenues is not based directly on unit case volume, we believe unit case volume performance is one of the measures of the underlying strength of the Coca-Cola system because it measures trends at the consumer level.
Unit case volume in Europe, Middle East and Africa increased 11 percent, which included 10 percent growth in Trademark Coca-Cola, 9 percent growth in sparkling flavors, 17 percent growth in hydration, sports, coffee and tea, and 18 percent growth in nutrition, juice, dairy and plant-based beverages. The operating segment reported growth in unit case volume of 14 percent in the Europe operating unit, 9 percent in the Africa operating unit and 8 percent in the Eurasia and Middle East operating unit.
Unit case volume in Latin America increased 9 percent, which included 7 percent growth in Trademark Coca-Cola, 13 percent growth in hydration, sports, coffee and tea, 9 percent growth in sparkling flavors, and 16 percent growth in nutrition, juice, dairy and plant-based beverages. The operating segment’s volume performance included 14 percent growth in Brazil and 4 percent growth in Mexico.
Unit case volume in North America increased 5 percent, which included 6 percent growth in hydration, sports, coffee and tea, 7 percent growth in both sparkling flavors and nutrition, juice, dairy and plant-based beverages, and 1 percent growth in Trademark Coca-Cola.
Unit case volume in Asia Pacific increased 4 percent, which included 4 percent growth in both sparkling flavors and Trademark Coca-Cola, 11 percent growth in nutrition, juice, dairy and plant-based beverages, and 3 percent growth in hydration, sports, coffee and tea. The operating segment reported growth in unit case volume of 16 percent in the India and Southwest Asia operating unit, 9 percent in the ASEAN and South Pacific operating unit, and 4 percent in the Japan and South Korea operating unit, partially offset by a decline in unit case volume of 3 percent in the Greater China and Mongolia operating unit.
Unit case volume for Global Ventures increased 23 percent, driven by 32 percent growth in hydration, sports, coffee and tea, growth in energy drinks and even performance in nutrition, juice, dairy and plant-based beverages.
Unit case volume for Bottling Investments increased 8 percent, which primarily reflects growth in the Philippines and India.
Concentrate Sales Volume
During the three months ended April 1, 2022, worldwide concentrate sales volume increased 11 percent and unit case volume increased 8 percent compared to the three months ended April 2, 2021. Concentrate sales volume growth is calculated based on the amount sold during the reporting periods, which is impacted by the number of days. Conversely, unit case volume growth is calculated based on average daily sales, which is not impacted by the number of days in the reporting periods. The first quarter of 2022 had one less day when compared to the first quarter of 2021, which contributed to the differences between concentrate sales volume and unit case volume growth rates on a consolidated basis and for the individual operating segments during the three months ended April 1, 2022. In addition, for the Europe, Middle East and Africa and Latin America operating segments, the differences between concentrate sales volume and unit case volume growth rates during the three months ended April 1, 2022 were impacted by the timing of concentrate shipments, as certain bottlers adjusted inventory levels in an effort to manage through near-term supply chain disruptions as we enter the peak selling season in many markets. The difference between concentrate sales volume and unit case volume growth for the Asia Pacific operating segment was partially due to the resurgence of COVID-19 and the related lockdowns in China. We expect the differences between concentrate sales volume and unit case volume growth rates to lessen over the remainder of the year.
29


Net Operating Revenues
During the three months ended April 1, 2022, net operating revenues were $10,491 million, compared to $9,020 million during the three months ended April 2, 2021, an increase of $1,471 million, or 16 percent.
The following table illustrates, on a percentage basis, the estimated impact of the factors resulting in the increase (decrease) in net operating revenues on a consolidated basis and for each of our operating segments:
Percent Change 2022 versus 2021
Volume1
Price, Product & Geographic Mix Foreign Currency Fluctuations
Acquisitions & Divestitures2
Total
Consolidated 11  % % (4) % % 16  %
Europe, Middle East & Africa 15  % % (9) % —  % 13  %
Latin America 20  19  (6) —  34 
North America 11  —  22 
Asia Pacific —  (5) —  1 
Global Ventures 22  12  (6) —  28 
Bottling Investments (5) —  8 
Note: Certain rows may not add due to rounding.
1Represents the percent change in net operating revenues attributable to the increase (decrease) in concentrate sales volume for our geographic operating segments and our Global Ventures operating segment (expressed in unit case equivalents) after considering the impact of acquisitions and divestitures. For our Bottling Investments operating segment, this represents the percent change in net operating revenues attributable to the increase (decrease) in unit case volume computed by comparing the total sales (rather than the average daily sales) in each of the corresponding periods after considering the impact of structural changes, if any. Our Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only after considering the impact of structural changes, if any. Refer to the heading “Beverage Volume” above.
2Includes structural changes, if any. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above.
Refer to the heading “Beverage Volume” above for additional information related to changes in our unit case and concentrate sales volumes.
“Price, product and geographic mix” refers to the change in net operating revenues caused by factors such as price changes, the mix of products and packages sold, and the mix of channels and geographic territories where the sales occurred. The impact of price, product and geographic mix is calculated by subtracting the change in net operating revenues resulting from volume increases or decreases, changes in foreign currency exchange rates, and acquisitions and divestitures from the total change in net operating revenues. Management believes that providing investors with price, product and geographic mix enhances their understanding about the combined impact that the following items had on the Company’s net operating revenues: (1) pricing actions taken by the Company and, where applicable, our bottling partners; (2) changes in the mix of products and packages sold; (3) changes in the mix of channels where products were sold; and (4) changes in the mix of geographic territories where products were sold. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.
Price, product and geographic mix had a 7 percent favorable impact on our consolidated net operating revenues. Price, product and geographic mix was impacted by a variety of factors and events including, but not limited to, the following:
Europe, Middle East and Africa — favorable channel and package mix and favorable pricing initiatives, including inflationary pricing in Turkey, partially offset by unfavorable geographic mix;
Latin America — favorable pricing initiatives, including inflationary pricing in Argentina, along with favorable channel and package mix;
North America — favorable pricing initiatives, including a benefit resulting from the timing of price increases in the prior year, and favorable channel and product mix;
Asia Pacific — favorable pricing initiatives along with favorable channel, package and geographic mix;
Global Ventures — favorable channel mix, primarily due to the timing of Costa retail store reopenings in the United Kingdom in the prior year, and favorable product mix; and
Bottling Investments — favorable pricing initiatives.
30


The favorable channel and package mix for the three months ended April 1, 2022 in all applicable operating segments was primarily a result of the continued recovery in away-from-home channels in many markets in the current year and the impact of shelter-in-place and social distancing requirements in the prior year.
Fluctuations in foreign currency exchange rates decreased our consolidated net operating revenues by 4 percent. This unfavorable impact was primarily due to a stronger U.S. dollar compared to certain foreign currencies, including the Turkish lira, euro, Japanese yen and Philippine peso, which had an unfavorable impact on our Europe, Middle East and Africa, Asia Pacific and Bottling Investments operating segments. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially offset by the impact of a weaker U.S. dollar compared to certain other foreign currencies, including the Chinese yuan, which had a favorable impact on our Asia Pacific operating segment. Refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.
“Acquisitions and divestitures” generally refers to acquisitions and divestitures of brands or businesse